<html>

<head>
<style type="text/css">.replbq{width:100%}</style>

<meta http-equiv="Content-Type" content="text/html; charset=windows-1252">
<META NAME="description" CONTENT=" Mukto-mona encourages rationalism among our members.">
<META NAME="keywords" CONTENT="Rationalism,Mukto-mona, Mehul Kamdar&nbsp;  ">
<title>Evolution of skin colour in dif­fe­rent human populations Olav Albert 
Christophersen </title>
<META NAME="description" CONTENT=" We condemn the verdict on Taslima Nasrin meted out by the court of Gopalganj, Bangladesh.">
<META NAME="keywords" CONTENT="Taslima Nasrin, Nasreen, Gopalganj, verdict, one year prison, blasphemy, Bangladesh, Islamisation, Mukto-mona">

<style>
<!--
 li.MsoNormal
	{mso-style-parent:"";
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman";
	margin-left:0in; margin-right:0in; margin-top:0in}
.small { font-family: verdana,arial,helvetica,sans-serif; font-size: x-small; }
.replbq{width:100%}h1
	{margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Times New Roman";
	font-weight:normal; margin-left:0pt; margin-right:0pt; margin-top:0pt}
span.MsoFootnoteReference
	{vertical-align:super}
-->
</style>

</head>

 

 <body bgproperties="fixed">

<blockquote>
  <p align="center">
  <img name="index_r1_c1" src="../../new_site/mukto-mona/images/index_r1_c1.gif" border="0" alt="" width="800" height="107"></p>
  <div align="center">
    <table id="AutoNumber2" borderColor="#111111" cellSpacing="0" cellPadding="0" width="606" border="0">
		<tr>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../index.html">
			<img src="https://gold.mukto-mona.com/new_site/mukto-mona/images/index_r3_c1.gif" border="0" width="153" height="19"></a></td>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../new_site/mukto-mona/muk-articles.html">
			<img src="https://gold.mukto-mona.com/new_site/mukto-mona/images/index_r6_c1.gif" border="0" width="153" height="19"></a></td>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../new_site/mukto-mona/muk-science.html">
			<img src="https://gold.mukto-mona.com/new_site/mukto-mona/images/index_r8_c1.gif" border="0" width="153" height="19"></a></td>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../new_site/mukto-mona/muk-rationalism.html">
			<img src="https://gold.mukto-mona.com/new_site/mukto-mona/images/index_r9_c1.gif" border="0" width="153" height="19"></a></td>
		</tr>
		<tr>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../new_site/mukto-mona/muk-humanrights.html">
			<img border="0" src="../../new_site/mukto-mona/images/index_r10_c1.gif" width="153" height="19"></a></td>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../new_site/mukto-mona/muk-currentaffairs.html">
			<img border="0" src="../../new_site/mukto-mona/images/index_r11_c1.gif" width="153" height="19"></a></td>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../new_site/mukto-mona/muk-literature.html">
			<img border="0" src="../../new_site/mukto-mona/images/index_r12_c1.gif" width="153" height="19"></a></td>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../new_site/mukto-mona/muk-bengaliheritage.html">
			<img border="0" src="../../new_site/mukto-mona/images/index_r13_c1.gif" width="153" height="19"></a></td>
		</tr>
	</table>
	<hr color="#FFFFFF">
    <table cellSpacing="0" cellPadding="0" width="600" border="0">
      <tbody>
        <tr>
          <td colSpan="2" rowSpan="3">
          <img src="../../1971/image_article/lcurv.gif" border="0" width="19" height="24"></td>
          <td class="k" bgColor="#6fb1d9">
			<img height="1" src="../../1971/image_article/spacer.gif" width="100%" border="0"></td>
          <td align="right" colSpan="2" rowSpan="3">
          <img src="../../1971/image_article/rcurv.gif" border="0" width="15" height="24"></td>
        </tr>
        <tr>
          <td class="h" bgColor="#eef5fa" height="22">
            &nbsp;
          </td>
        </tr>
        <tr>
          <td class="k" width="1" bgColor="#6fb1d9">
          <img src="../../1971/image_article/spacer.gif" border="0" width="1" height="1"></td>
        </tr>
        <tr>
          <td class="k" width="1" bgColor="#6fb1d9">
          <img src="../../1971/image_article/spacer.gif" border="0" width="1" height="1"></td>
          <td width="18" bgColor="white">
			<img height="1" src="../../1971/image_article/spacer.gif" width="18" border="0"></td>
          <td bgColor="#FFFFFF">
  <table border="1" width="48%">
  </table>
	<div class="doc-layout-body">
		<p align="center"><font face="Verdana" color="#800000"><b>
		<span style="font-size: 14.0pt; font-family: CG Times">Evolution of skin 
		colour in different human populations</span></b></font></div>
	<h3 align="center"><font face="Verdana" color="#000080">
	<span lang="EN-GB" style="font-family: CG Times; font-weight: 700">Olav 
	Albert Christophersen </span></font></h3>
	<p align="center"><font face="Verdana" color="#000080">
	<span style="font-family: CG Times; font-weight: 700">Fwd : Asim K. Duttaroy</span></font></p>
	<font size="2">
	<p align="center">
  <b><font face="Verdana" color="#6FB1D9">Published
	on
	<!--webbot bot="Timestamp" S-Type="REGENERATED" S-Format="%B %d, %Y" startspan -->February 13, 2007<!--webbot bot="Timestamp" i-checksum="41405" endspan --></font></b></p>
        </font>
		<p align="center">&nbsp;</p>
	<blockquote>
		<p>Dear Moderator, </p>
		<p>Please find the attached article on Evolution of skin colour in 
		different human populations by Olav Albert Christophersen, for 
		publication in your website. My friend, Olav Albert is a great science 
		writer in Norway. He has written many scientific articles of high 
		quality, and thought provoking too. I have seen some recent articles on 
		evolution in your website. I thought it would be nice to include this 
		article related to the evolution issue. I am forwarding this article 
		with his permission for publication in your website. I am very happy to 
		introduce him to your readers. </p>
		<p>I will send you soon my own article on &quot;<b>Epigenetics, the imprinted 
		genes, maternal mitochondria, and the eternal battle of the sexes</b>&quot; 
		which is being written for a popular medical journal. </p>
		<p>I hope your readers will enjoy reading this article. </p>
		<p>With Kind Regards Yours Sincerely </p>
		<p>Dr. Asim K. Duttaroy </p>
		<p>===================================<br>
		Dr. Asim K. Duttaroy<br>
		Professor, Faculty of Medicine<br>
		University of Oslo<br>
		POB 1046 Blindern<br>
		N-0316 Oslo<br>
		Norway</p>
		<p>===================================</p>
		<p><br>
&nbsp;</p>
	</blockquote>
	<p class="MsoFootnoteText" align="center">
	<font face="Verdana" color="#800000"><b>
	<span lang="EN-GB" style="font-size: 14.0pt; font-family: CG Times">
	Evolution of skin colour in different human populations</span></b></font></p>
	<p class="MsoFootnoteText" align="center">
	<font face="Verdana" color="#000080">
	<span lang="EN-GB" style="font-family: CG Times; font-weight: 700">&nbsp;Olav 
	Albert Christophersen,&nbsp; Norway</span></font></p>
	<p class="MsoFootnoteText"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Light skin 
	colour must be understood as an evolutionary adaptation that has helped to 
	increase the pho­to­che­mical synthesis of vitamin D (by solar ultraviolet 
	radiation) in the skin among peop­le who were li­ving at higher la­ti­tu­des 
	and/or under cold climatic conditions at the same time as their dietary 
	intake of vi­ta­min D was low. Most foods eaten by humans (with some few 
	exceptions, like cod liver and cod liver oil, or foods that have been 
	fortified with this vitamin) contain very little vitamin D, and the 
	requirements for the vitamin are most commonly – when we consider 
	populations living at not too high latitudes - covered not by the diet, but 
	by ultraviolet-B light-induced photochemical degradation of a precursor 
	mo­le­cu­le, 7-dehydrocholesterol, in the skin.<a name="_ftnref1" title href="#_ftn1"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[1]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UVB light is 
	absorbed by ozone in the atmosphere, and the amount of UVB light reaching 
	the ground depends both on the path-length of the solar light through the 
	atmo­sphe­re be­fo­re it reaches the ground (be­ing shortest when the sun is 
	in zenith) and on the con­cen­tra­tions of ozone in the air, especially in 
	the stra­tosphere.<a name="_ftnref2" title href="#_ftn2"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[2]</span></span></a> 
	The amounts of ozo­ne in the stra­tosphere are highest at middle 
	la­ti­tu­des, from where they decrease both to­wards the Equa­­tor and to a 
	lesser extent to­wards the poles.<a name="_ftnref3" title href="#_ftn3"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[3]</span></span></a> 
	However, ozone levels in the polar areas are now abnormally low, 
	es­pe­ci­ally in the Antarctic, as a result of anth­ro­po­ge­nic 
	pol­lu­tion.<a name="_ftnref4" title href="#_ftn4"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[4]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UVB radiation 
	at the ground is much stronger near the Equator than at middle la­ti­tudes, 
	since the ave­rage passage length for the UV radiation through the 
	atmosphere is shorter simul­ta­ne­ously as the ozone concentrations in the 
	air masses in the stra­to­sphe­re also are lower, com­paring 
	near-equa­torial latitudes to the middle latitudes. There is normally less 
	change in the levels of UVB radiation reaching the ground when one compares 
	middle and high latitudes. This is because the enhancement of the average 
	passage length for the sun’s rays through the atmosphere as one goes from 
	middle to high latitudes is partly com­pensated by a si­mul­ta­neous 
	reduction in the ozone concentrations of air masses in the stra­to­sphere.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; But vitamin D 
	synthesis in the skin of humans is decreased from middle to high 
	la­ti­tu­des (as well as from low to middle latitudes) also for another 
	reason, <i>viz</i><b>. the reduction of ground tem­pe­ratures ma­king it 
	necessary to use more clothes even during the summer months.<a name="_ftnref5" title href="#_ftn5"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[5]</span></span></a></b> 
	The area of skin which is di­rect­ly exposed to UVB radiation will then be 
	cor­res­pon­ding­ly reduced. Lo­cal tem­pe­ratures depend, of course, not 
	only on la­ti­tu­de but also on other factors such as ocea­nic currents, 
	distance from the nearest coast and altitude, as well as on global changes 
	of climate, espe­ci­ally when we compare the Ice Ages with the situation 
	today. How much clothes are needed depends also on other meteo­ro­lo­gical 
	factors such as wind velo­cities and rainfall, as well as on the level of 
	physical activity.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The temperature 
	differences, comparing the situation in the same geographical areas during 
	cold pha­ses of the Ice Age and now, are so large that there can be no doubt 
	that people who were living in Europe or in the Asian inland during cold 
	phases of the Ice Age must have needed more clothes than people who are 
	li­ving in the same areas today. The Oceanic Polar Front in the North 
	Atlantic Ocean, corresponding with the southern limit (2<sup>o</sup>C) of 
	cold Arctic surface water, went much further south than now.<a name="_ftnref6" title href="#_ftn6"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[6]</span></span></a>&nbsp; 
	Arctic surface waters with drifting sea ice were found as far south as 
	outside the present Atlantic coasts of France and northern Spain,<a name="_ftnref7" title href="#_ftn7"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[7]</span></span></a> 
	and wild rein­deer were living as far south as in southwestern France and 
	northern Spain.<a name="_ftnref8" title href="#_ftn8"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[8]</span></span></a> 
	It has been estimated that the average summer tem­pe­rature in these areas 
	may have been about 15<sup>o</sup>C.<a name="_ftnref9" title href="#_ftn9"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[9]</span></span></a> 
	But this estimate is most probably too high, since it is probable that the 
	amount of cooling must have been con­si­de­rably larger in southwestern 
	France – at a time when there was drifting ice in the Bis­cayan Gulf – than 
	in the Oman desert at the same time. And the average annual tem­pe­rature in 
	the Oman desert was about 6.5 degrees centigrade colder than now during the 
	Last Glacial Ma­xi­mum.<a name="_ftnref10" title href="#_ftn10"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[10]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An important 
	reason why the global climate was much colder than now was <b>a much lower 
	con­cen­tra­tion of CO<sub>2</sub> in the atmosphere.</b><a name="_ftnref11" title href="#_ftn11"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[11]</span></span></a> 
	Measurements of CO<sub>2 </sub>concentrations in ice-cores (from the 
	icesheets in Antarctica and on Greenland) indicate that atmo­sphe­ric CO<sub>2</sub> 
	concentrations were consistently about 80 parts per million lower during 
	glacial periods com­­pared with interglacial periods.<a name="_ftnref12" title href="#_ftn12"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[12]</span></span></a> 
	There may have beeen more than one reason for this, but it is possible that 
	one of the most important causes was <b>more sea-ice cover in the 
	Ant­arc­tic, which resulted in reduced discharge of CO<sub>2</sub> into the 
	atmosphere from deep­wa­ters upwelling in the Antarctic</b> (because the 
	sea-ice was functioning as a lid hindering CO<sub>2</sub> exchange between 
	the surface seawater and the air).<a name="_ftnref13" title href="#_ftn13"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[13]</span></span></a> 
	It might be noted that <b>enhanced anth­ropogenic global warming must be 
	expected to lead even more reduction of the sea-ice cover in the Antarctic</b> 
	(compared with the situation today), which might lead to fur­ther 
	enhancement of the flux of CO<sub>2</sub> from deep­waters up­welling in the 
	Antarctic into the atmo­sphe­re (with this effect – being analogous to 
	scre­wing off the lid of a bottle of mineral water - coming on top of the 
	direct anth­ro­po­genic con­tri­bu­tion&nbsp; to en­han­cement of atmo­sphe­ric 
	CO<sub>2</sub>).</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Another 
	possible contributory cause that might help to explain the depression of 
	at­mospheric CO<sub>2</sub> during cold intervals during the Ice Age may 
	have been larger air-borne iron supply than now to the Southern Ocean.<a name="_ftnref14" title href="#_ftn14"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[14]</span></span></a> 
	Iron is today a growth-limiting plant nutrient in this region; <i>i.e.</i> 
	the growth of planktonic algae can be stopped by iron deficiency before it 
	is stopped by deficiency of other plant nutrients such as phosphate, 
	nitrogen or silicon.<a name="_ftnref15" title href="#_ftn15"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[15]</span></span></a> 
	En­han­­cement of the supply of iron may therefore have given a 
	fertilization effect; <i>i.e</i>. it may have caused enhanced algal growth 
	(compared with the situation today) and hence enhanced CO<sub>2</sub> 
	binding by pho­to­syn­the­sis, which would lead to reduction of the CO<sub>2</sub> 
	partial pressure in the surface wa­ters in areas of open sea with­out ice 
	co­ver.<a name="_ftnref16" title href="#_ftn16"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[16]</span></span></a> 
	&nbsp;</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It has been 
	shown from studies of glacier ice cores that not only CO<sub>2</sub>, but 
	also me­tha­ne (CH<sub>4</sub>) con­cen­­tra­tions in the atmosphere were 
	depressed at the time of the Last Glacial Maximum compared to the warm 
	in­ter­val that followed.<a name="_ftnref17" title href="#_ftn17"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[17]</span></span></a> 
	The same happened also with N<sub>2</sub>O.<a name="_ftnref18" title href="#_ftn18"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[18]</span></span></a> 
	Methane and N<sub>2</sub>O are also important atmospheric greenhouse gases.<a name="_ftnref19" title href="#_ftn19"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[19]</span></span></a> 
	Both can be pro­du­ced by bio­logical processes in oxygen-deficient 
	environments,<a name="_ftnref20" title href="#_ftn20"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[20]</span></span></a> 
	even though N<sub>2</sub>O can also be produced bio­lo­gi­cally when 
	ammonium is oxi­di­zed by bacteria to nitrite and nitrate.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After water 
	vapour and CO<sub>2</sub>, methane is now the most abundant greenhouse gas 
	in the tropo­sphe­re.<a name="_ftnref21" title href="#_ftn21"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[21]</span></span></a> 
	On a per molecule basis, methane has a much greater climate warming 
	potential than CO<sub>2</sub>.<a name="_ftnref22" title href="#_ftn22"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[22]</span></span></a> 
	It is pro­du­ced in oxygen-deficient wetland habitats such as swamps, lakes, 
	rice paddies, tundra, boreal marshes, etc., and also in the rumen of cattle 
	and other ruminants, as well as in the digestive tracts of termites and 
	perhaps other in­sects.<a name="_ftnref23" title href="#_ftn23"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[23]</span></span></a> 
	The rate of methane production is highest in tro­pical wetlands,<a name="_ftnref24" title href="#_ftn24"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[24]</span></span></a> 
	which may perhaps reflect the in­flu­en­ce of temperature on rates of 
	biochemical processes not only in higher organisms, but most pro­bab­ly in 
	an­ae­­ro­bic archaebacteria including the metha­no­gens as well. Tropical 
	soils are probably also the most important natural source of N<sub>2</sub>O 
	for the atmosphere today.<a name="_ftnref25" title href="#_ftn25"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[25]</span></span></a> 
	The total con­tribution from the oceans as sources of N<sub>2</sub>O is 
	comparable to the total contribution from tro­pi­cal soils.<a name="_ftnref26" title href="#_ftn26"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[26]</span></span></a></span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is probable 
	that the total re­lea­se of methane and N<sub>2</sub>O from land areas into 
	the at­mo­sphere must have been reduced during cold phases of the Ice Age 
	not only because there was practically no methane and N<sub>2</sub>O release 
	from areas covered by glaciers, but also be­cau­se of greater all-over 
	aridity over land as a result of the reduction of sea-surface 
	tem­pe­ra­tu­res causing reduction of the total rate of water evaporation 
	from the sea. Changes in the tem­­perature conditions over land may also 
	have played some role, but was pro­bably less important than the changes of 
	precipitation causing enhancement of the total land area co­ve­red by 
	deserts, at the same time as the total area covered by tropical rainforests 
	was sub­stan­­tially less than during post-glacial times.<a name="_ftnref27" title href="#_ftn27"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[27]</span></span></a> 
	The total emission of methane and N<sub>2</sub>O from tropical wetlands was 
	therefore most probably much re­du­ced, compared with the situation during 
	postglacial times.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The direction 
	and possible magnitude of changes of total methane and N<sub>2</sub>O fluxes 
	from the sea into the atmosphere, comparing cold phases during the Ice Age 
	with the situa­tion today, is more difficult to esti­mate. The total flux of 
	methane from the oceans into the atmosphere may today represent less than 
	10% of the total methane flux from terrestrial and freshwater ecosystems,<a name="_ftnref28" title href="#_ftn28"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[28]</span></span></a> 
	may be only some few percent of the latter.<a name="_ftnref29" title href="#_ftn29"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[29]</span></span></a> 
	The oceans, how­ever, make a very significant contribution to the global 
	atmo­sphe­ric budget for N<sub>2</sub>O.<a name="_ftnref30" title href="#_ftn30"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[30]</span></span></a> 
	Lo­cal fluxes of the­se gases from the sea into the at­mo­sphere may during 
	the Ice Age have been en­han­ced in some parts of the world and de­creased 
	in other pla­ces (compared with the si­tua­tion today), depending in part on 
	whether there was more or less upwelling in the re­gion con­­­cer­­­ned than 
	now, but also on changes in the extension of sea ice cover.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It may be 
	possible that total rates of upwelling near the Equator may have been higher 
	during cold phases of the Ice Age than now. This may have happened <i>i.a.</i> 
	as a con­sequence of changes in global sea-sur­face topography (because of 
	the Coriolis effect acting transversely to the direction of oceanic 
	currents) re­sul­ting from the shutting-down of large-scale sin­king 
	processes in the North Atlantic Ocean during cold phases of the Ice Age,<a name="_ftnref31" title href="#_ftn31"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[31]</span></span></a> 
	at the same time as larger meridional temperature gradients than now 
	(be­cau­se Ice Age cooling was substantially greater at high latitudes than 
	near the Equa­tor) must be ex­pec­ted to have caused an over-all 
	intensification of zonal winds, in­clu­ding the passat winds, in the 
	atmo­sphe­re, which may in turn have led to a corres­pon­ding en­han­cement 
	of the rates of many (but not all) of the corres­ponding oceanic cur­rents, 
	in­clu­ding the equatorial current systems both in the Atlantic and Pacific 
	oceans. If the global rate of equa­torial upwel­ling was en­han­ced, this 
	must be expected to have caused some drop of ave­rage sea surface 
	tem­pe­ra­tu­res (SSTs) near the equator (with the effect of en­han­ced 
	up­wel­ling on local SSTs coming in addition to that of less greenhouse 
	gases in the atmo­sphere), but most probably also enhan­ce­ment of total 
	rates of eva­poration of bio­lo­gically produced dimethylsulfide, 
	dime­thyl­se­lenide, methyl­bro­mide, methyl­iodide and N<sub>2</sub>O from 
	the regions of equatorial up­wel­ling.<a name="_ftnref32" title href="#_ftn32"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[32]</span></span></a> 
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On the other hand, it must be expected that a greater total 
	extension of the sea ice cover must have led to consi­de­rab­le reduction of 
	total fluxes of these gases into the atmo­sphere from the sea at higher 
	latitudes, since the sea ice would not only cause some degree of inhibition 
	of primary production below because of its shadow effect, but also must have 
	acted directly as a lid effectively preventing all processes of gas exchange 
	between surface sea­waters and the atmosphere. What may have been especially 
	important was the larger ex­tension of the sea ice cover in the Antarctic, 
	since all the region concerned is today part of an enormous up­wel­ling 
	region characterized today by high biological productivity (with large 
	production of diatoms which are eaten by krill – with part of the krill next 
	being eaten by whales). The Antarctic seas do represent a sig­ni­fi­cant 
	source of N<sub>2</sub>O to the at­mo­sphere today,<a name="_ftnref33" title href="#_ftn33"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[33]</span></span></a> 
	most probably mainly as a consequence of N<sub>2</sub>O production during 
	nit­ri­fi­ca­tion (ammonium oxidation) rather than during denitrification 
	(nitrate or nitrite re­duc­tion). This is because the free water masses in 
	the region may contain too much oxy­gen for de­nit­rification to occur 
	except within the sedi­ments at the ocean floor.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Water vapour is 
	the most important one of all atmospheric greenhouse gases today. But the H<sub>2</sub>O/N<sub>2
	</sub>mi­xing ratio is not constant, but depends strongly on the temperature 
	of the air. When the temperature of the troposphere is reduced because of 
	reduction of the con­cen­trations of other greenhouse gases, this will lead 
	to reduction of the H<sub>2</sub>O vapor con­cen­tra­tion which leads to 
	reduction of the greenhouse effect from H<sub>2</sub>O as well, which means 
	in turn that there will be an amplification of the effect from the primary 
	signal (<i>e.g.</i> a re­duc­tion of the concentration of CO<sub>2</sub> in 
	the air).</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stratospheric 
	ozone is also an important greenhouse gas. It may be possible that 
	stratospheric ozone levels had a tendency to go up during cold phases of the 
	Ice Age at the same time as levels of other green­hou­se gases went down. 
	But even if there should have been more ozone in the stratosphere than now 
	(because of higher stratospheric temperature with less CO<sub>2</sub>, and 
	also because of reduced supply of N<sub>2</sub>O to the strato­sphe­re), 
	this would not have been enough to compensate for the climatic effect of 
	much lower concentrations of CO<sub>2</sub> in the atmosphere than now at 
	the same time as there was also substantially less me­tha­ne, N<sub>2</sub>O 
	and water vapour. </span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The lower 
	concentration of CO<sub>2</sub> and other greenhouse gases in the air during 
	the cold intervals during the Ice Age must have caused a cor­res­ponding 
	reduction of the atmo­spheric ‘greenhouse effect’ (which is a consequence of 
	back radiation of inf­ra­red light from air masses higher up towards the 
	ground).<a name="_ftnref34" title href="#_ftn34"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[34]</span></span></a> 
	The rate of ground hea­ting during the day would thus be decreased (because 
	less inf­rared light would have come from the at­mo­sphe­re above, even if 
	the total energy flux coming directly from the sun should have been the 
	same), and the rate of cooling of the ground during clear, cloud-less nights 
	would be in­crea­sed. These factors must have had an important impact on the 
	local climate even in inland areas distant from the nearest coast (so that 
	changes of sea surface temperatures <i>e.g.</i> in the North At­lan­tic 
	Ocean would have little direct effect on temperatures over the land area 
	con­cerned) – <i>e.g.</i> in pla­ces like present Mongolia, western China or 
	Tibet. And they would also have af­fec­ted places where there was no glacier 
	co­ver be­cau­se of too small annual pre­ci­pitation (which was the case in 
	much of present Siberia and Alaska).</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ground 
	temperatures were reduced not only at high middle to high latitudes, but 
	probably all over the world as a result of the reduction of atmospheric CO<sub>2</sub> 
	concentrations as well as of some of the other green­hou­se gases during 
	Pleistocene glaciations. As an ex­amp­­le may be mentioned the situation in 
	Oman during a cold interval 15&nbsp;000 to 24&nbsp;000 be­fo­re present.<a name="_ftnref35" title href="#_ftn35"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[35]</span></span></a> 
	The solubility of atmospheric nob­le gases (Ne, Ar, Kr and Xe) in water is 
	tem­perature-dependent, which means that the concentrations of these gases 
	in water can be used to calculate the tem­pe­ra­ture when the water was last 
	in equilibrium with the atmo­sphe­re.<a name="_ftnref36" title href="#_ftn36"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[36]</span></span></a> 
	The average noble gas temperature (NGT) calculated for three Holocene 
	(post-glacial) water samples from the upper Al Khwas Fan aquifer is 33.5 +/- 
	1.7 <sup>o</sup>C.<a name="_ftnref37" title href="#_ftn37"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[37]</span></span></a> 
	&nbsp;These estimated infiltration temperatures closely agree with measured 
	groundwater tem­pe­rature and the ave­rage annual ground tem­pe­ra­tu­re at 
	the water table, <i>i.e.</i> 33 +/- 0.3 <sup>o</sup>C.<span class="MsoFootnoteReference">
	<a name="_ftnref38" title href="#_ftn38">
	<span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[38]</span></a></span> 
	But three Pleis­to­ce­ne (Ice Age) ground­wa­ter samples were found to yield 
	consistent NGTs between 26<sup>o</sup> and 27<sup>o</sup>C, with an average 
	of 26.6<sup>o</sup> +/- 0.6<sup>o</sup>C, which is about 6.5<sup>o</sup> +/- 
	0.6<sup>o</sup>C less than the ave­rage annual ground tem­pe­ra­ture at the 
	water table today.<a name="_ftnref39" title href="#_ftn39"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[39]</span></span></a>
	<b>The average an­nu­al ground tem­perature in Oman 15&nbsp;000 to 24&nbsp;000 years 
	ago appears therefore to have been about 6.5<sup>o</sup>C lower than in the 
	same region today.</b></span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is 
	reasonable to believe that this mainly may reflect a change of the 
	temperature cor­responding to local radiation equilibrium (because of the 
	reduction of the atmospheric green­house effect) rather than a chan­ge of 
	wind temperatures (for air masses coming in from somewhere outside the area 
	under consideration). This is because the clear skies found in desert areas 
	are associated with so high rates of direct solar energy absorbtion during 
	the day and so high rates of cooling as a result of infrared radiation from 
	the ground during the night that these processes will dominate the local 
	energy budget, making heat gains and los­ses by ad­vec­tion (<i>i.e.</i> 
	heat transport by the winds) relatively less important. It is not 
	pro­bab­le, for instance, that those ice-sheets that covered much of North 
	America and north­west Europe during the same period would have any 
	significant influence on tem­pe­ra­tures in the desert in Oman.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Another kind of 
	evidence showing that Ice Age temperatures must have been lower than today, 
	even near the Equator, is the substantial depression of the snowline that 
	took place on the high mountains of East Africa, such as Kilimandjaro and 
	Mount Kenya. The position of the snowline is not uniquely a function of the 
	mean annual temperatures, but depends also on the distribution of 
	precipitation between different parts of the year. How­ever, this latter 
	factor must be less important near the Equator than at higher latitudes, 
	where there are much more pronounced winter and summer seasons. It is 
	estimated that the temperature 20&nbsp;000-18&nbsp;000 years ago was lower than today 
	in most of Africa, in the order of 7 degrees centigrade colder in parts of 
	East Africa.<a name="_ftnref40" title href="#_ftn40"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[40]</span></span></a> 
	This can be seen to be close to the change of temperature (using an entirely 
	different me­thod) that was found in Oman. Sea surface paleotemperatures can 
	be estimated from <sup>18</sup>O/<sup>16</sup>O isotopic ratios of siliceous 
	or cal­ca­reous tests of fossil planktonic orga­nisms,<a name="_ftnref41" title href="#_ftn41"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[41]</span></span></a> 
	but must be corrected for changes in salinity (which will chan­ge the <sup>
	18</sup>O/<sup>16</sup>O isotopic ratio of the sea­wa­ter itself). An 
	independent method of estimating pa­leosalinity is therefore nee­ded, if 
	this method shall give answers that are precise enough to be useful for 
	geo­phy­si­cists stu­dying world climates during the Ice Age.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A depression of 
	the annual average temperature from 33<sup>o</sup>C to 26.6<sup>o</sup>C in 
	Oman would not have caused people who were living on the Arabian Peninsula 
	during the Ice Age to freeze, at least not during the day, while a similar 
	reduction of the annual average tem­pe­ra­ture must have been strongly felt 
	by people living in what is now Den­mark, Germany, Poland, Russia or 
	Mongolia (and it may be possible that the reduction of average annual 
	temperature may have been even larger in many of these areas than it was in 
	the desert of Oman). Actually, there is good reason to suspect that the drop 
	of average annual tem­pe­ra­ture must have been even larger at higher 
	latitudes than it was in Oman, since the relative contribution of water 
	vapour to the total atmospheric greenhouse effect decreases as one goes from 
	lower to higher latitudes (with lower temperature and therefore lower H<sub>2</sub>O 
	va­pour concentration in the air). A drop of atmospheric CO<sub>2</sub> 
	concentration from about 300 ppm (by volume) to about 200 ppm would 
	presumably have a greater effect on ground temperatures corresponding to 
	local radiation equilibrium in regions where the air is very dry than in 
	regions near the Equa­­tor where H<sub>2</sub>O concentrations in the lower 
	troposphere are much higher. The same argument might also suggest that 
	winter temperatures may have been even more strongly affected than summer 
	temperatures by a substantial drop of the atmospheric CO<sub>2</sub> 
	concentration.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Direct 
	measurements of the temperature in drillcore samples from the Greenland 
	ice-sheet have shown that the temperature at the top of the glacier was 
	about 23 degrees Kelvin less than now during the Last Glacial Maximum.<a name="_ftnref42" title href="#_ftn42"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[42]</span></span></a> 
	The impact of less atmospheric green­house gases than now on the local 
	radiation ba­lan­ce and ground tempe­ra­ture may therefore have been more 
	than three times larger on top of the Green­land ice-sheet compared to 
	desert in Oman.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The amount of 
	Ice Age cooling in Siberia (comparing the situations during the Last Glacial 
	Maxi­mum and now) was presumably in a range intermediate between those 
	values that have been found, respec­ti­vely, on the surface of the Greenland 
	ice-sheet and in Oman, but may most likely (taking into consideration the 
	effect of local temperature on concen­tra­tions of water vapour in the 
	troposphere) have been closer to the amount of cooling ob­ser­­ved in 
	Greenland than to the amount of cooling observed in Oman. There can be no 
	doubt, however, that people who were living in central and perhaps northern 
	parts of Eurasia during the Ice Age must have known how to keep themselves 
	warm, similarly as we know that for instance Inuits or Saami people have 
	done during his­to­rically more recent times. But it can not have been very 
	easy to do so, if the ave­rage an­nual temperatures in much of the interior 
	of Eurasia were depressed by more than 14 degrees cen­tigrade, compared with 
	the ave­rage annual temperatures in the same places today. Even better 
	clothes might have been needed – as protection against extreme cold - than 
	are needed in order to keep warm by Inuits today. Such drastic depression of 
	the ave­ra­ge annual tempe­rature could imply not only sub­stan­tially lower 
	winter temperatures than in the same regions today, but also sub­stan­tially 
	lower summer tempera­tures making it much more difficult <i>e.g.</i> for 
	small children to go with much of the skin exposed to the sun’s rays even 
	during the summer months.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It may be 
	possible that it was not temperature <i>per se</i> which was the most 
	important factor de­ter­mi­ning where it was possible or not for Ice Age 
	hunters to survive, but rather the availability of enough food re­sources. 
	The extreme temperature conditions encountered in much of Siberia during the 
	Ice Age must, how­ever, have represented a substantial chal­lenge not only 
	to humans, but to other mammalian species as well. It may be possible that 
	very large species such as the mammoth may have tolerated very low winter 
	tem­pe­ra­tu­res bet­ter than not quite so big ones such as the reindeer 
	(because the ratio body surfa­ce/body mass and hence the cooling rate for a 
	warm-blooded animal goes down as a func­tion of increasing body mass).</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; But even if the 
	largest mammalian species such as the mammoth may have been even better 
	adapted for extreme cold compared <i>e.g.</i> with the reindeer, they must 
	also have been more vulnerable to hunting be­cau­­se of their slow 
	re­pro­duc­tion. It may thus be possible that they may have managed to 
	survive as long as the popu­la­tion density for humans was very low (because 
	of some limiting factor other than the number of mam­moths), or when the 
	climate was so harsh as to keep the hu­mans ef­fec­ti­vely out from 
	sub­stan­tial stretches of the Siberian territory. Global warming during the 
	Bøl­ling/Al­lerød inter­stadial and/or after the end of the Youn­­ger Dryas<a name="_ftnref43" title href="#_ftn43"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[43]</span></span></a> 
	may, however, have been accompanied by substantial mig­ration both of 
	rein­deer populations and of rein­deer hunters to the north, which again may 
	have led to so much en­han­cement of the hunting pres­su­re on the mammoths 
	even in the coldest parts of Si­be­ria that the latter had no 
	geo­gra­phi­cal refugium left any more where it might have been possible for 
	them to survive. It may not be un­rea­sonable that a similar process also 
	could help to explain the extinction of va­ri­ous large mammalian spe­cies 
	in North Ame­rica at more or less the same time.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In spite of 
	very harsh climate, there can be little doubt that there must have been 
	humans throughout much of Central Asia and possibly also further north 
	throughout much of the last Ice Age. While only ar­chaeo­­logical evidence 
	can give us direct proof that there were humans within a given geographical 
	region at one particular time interval, it is also possible to draw some 
	important conclusions from more indirect evi­den­ce pertaining to the 
	genetic diversity among human populations now living within some of the 
	territories con­cerned. Studies of human Y chromosomes have shown that total 
	Y chromosome diversity is high among na­ti­ve Siberian populations.<a name="_ftnref44" title href="#_ftn44"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[44]</span></span></a> 
	In a study of Y-chromosome diverity in 50 dif­fe­rent populations from 
	different parts of the world, the highest level of Y-chromosome 
	hete­rozygocity was found in populations from Central Asia, while African 
	populations exhibited a higher level of mean pairwise differences among 
	haplotypes.<a name="_ftnref45" title href="#_ftn45"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[45]</span></span></a> 
	Cen­tral Asia is revealed to be an important reservoir of genetic diversity 
	and the source of at least three major waves of migration leading into 
	Europe, the Americas and India.<a name="_ftnref46" title href="#_ftn46"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[46]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The high total 
	level of Y-chromosome diversity that has been observed among native Siberian 
	po­pu­lations as well as in Central Asia can most easily be ex­plained 
	assuming that the present human popu­la­tion in the region concerned has 
	des­cen­ded from popu­la­tions that have had a very long prehistory within 
	more or less the same terri­tory (or neigh­bour ter­ri­to­ries, allowing for 
	the possibility of substantial north-south mig­ra­tions in response to 
	changes in global climate), thus giving ample time for evolutionary 
	diversification of the Y chro­mo­somes, at the same time as many of the 
	tribes concerned also have been living so hostile ter­ri­to­ries that they 
	for that very reason may have been spared for massacres caused by foreign 
	invaders that other­wise might have led to substantial reduc­tion of Y 
	chromosome diversity. Thus, it may be possible that es­sen­tially modern 
	humans may have inhabited these terri­to­ries at a time when Neanderthalers 
	still were domi­na­ting (to the ex­clu­sion of modern hu­mans?) in much or 
	all of Western Europe.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There can be 
	little doubt that vitamin D deficiency must have been a widespread and 
	serious problem in the colder parts of Eurasia during the Ice Age (because 
	people needed to cover themselves with even more clothes than is needed in 
	the same geographical regions today), unless people were able to find foods 
	that were good sources for this vitamin. This would not have been difficult 
	for coastal tribes who were eating much sea mammals and/or fish (since the 
	livers both of cod and seal are excellent sources of this vitamin, and the 
	liver of ice bear contains so much vitamin D and vitamin A that it is toxic 
	and dangerous to eat). But it would have been more difficult for tribes 
	living in the inland without access to sea­foods rich in this vitamin – 
	which may be illustrated by the persistence in places like Mon­golia of 
	vitamin D deficiency as a major public health problem even today, or at 
	least until very recently.<a name="_ftnref47" title href="#_ftn47"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[47]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is well 
	documented that vitamin D is up-concentrated upwards in marine food-chains, 
	so that the vitamin D/lipid ratio is higher in cod liver than in whole 
	capelin (<i>Mal­lo­tus villosus</i>) or whole herring, even higher in the 
	livers of seal eating cod, and even higher than in seal liver in the liver 
	of ice-bear eating seals. It is not unreasonable that something similar also 
	may happen in food chains on land, so that livers from car­ni­vo­res (<i>e.g.</i> 
	wolf) or omnivores (<i>e.g.</i> bear) may contain more vitamin D than livers 
	from herbivores (<i>e.g.</i> mam­­­moth). The question might thus be raised 
	if some of those populations of inland hunters who were living in regions 
	with extremely harsh climate <i>e.g.</i> in parts of Siberia during the Ice 
	Age may have depended on bear liver as a source of vitamin D. If this was 
	the case, it may be possible that it was the availability of good dietary 
	sources of vi­ta­min D rather than the availability of food energy or 
	dietary protein which was the most important factor li­mi­ting human 
	population density in inland regions with especially harsh climate – thus 
	keeping the human popu­la­tion density so low that it would have been 
	possible for mammoths to survive even with scattered hunter po­pu­la­tions 
	dwelling permanently within the same territories.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The bear 
	liver/vitamin D hypothesis might also help to explain the close 
	etymolo­gi­cal connection between words meaning the animal bear and words 
	meaning ‘to give birth’ (such as the verb ‘bear’ in Eng­lish, being 
	identical with the noun used as name for the animal), as well as words such 
	as Norwegian ‘<i>barn</i>’ (meaning child) derived from words meaning ‘to 
	give birth’.<a name="_ftnref48" title href="#_ftn48"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[48]</span></span></a> 
	Other explanations have also been given for this etymological connection, as 
	well as for the bear cult which apparently must have been very wide­spread 
	in Europe during the Stone Age.<a name="_ftnref49" title href="#_ftn49"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[49]</span></span></a> 
	However, it might be an even more direct and more satis­factory explanation 
	for the etymological connection between words for the animal and for giving 
	birth, as well as for the bear cult, if there had been a widespread 
	under­stan­ding that girl children and/or their lactating mothers (while 
	still breast-feeding their youn­gest girl child) should eat bear liver in 
	order that the girls should be able to give birth without too serious 
	com­pli­ca­tions (because of malformation of the pelvis) after they had 
	grown up to become adult women.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It should be 
	emphasized that the problem of inadequate synthesis of vitamin D in the skin 
	may have gone much further south in the Eurasian inland than it does today – 
	when the inland climate gives high ave­rage summer temperatures <i>e.g.</i> 
	in southern parts of Siberia or in Mongolia, even if the winter temperatures 
	are low. It should, moreover, also be taken into consideration that the 
	summers, as now, may have been as­so­ciated with an­other prob­lem for many 
	of the populations concerned, even when tem­pe­ratures were high enough that 
	child­ren well might have gone naked – <i>viz.</i> mosquitoes and other 
	insects. There may thus have been many places where not only adults but also 
	children may have been well-covered by clothes for pro­tec­tion against 
	insects, even when day tem­pe­ra­tures were high enough that they well might 
	have gone completely naked with­out shi­ve­ring.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There may, 
	furthermore, also have been social and psy­cho­lo­gi­cal reasons why people 
	may have used more clothes than was needed for temperature regulation during 
	the summer - being connected with the sexual arousal a man may feel when 
	seeing such parts of a woman’s body that normally would be covered by 
	clo­thes. What is important here is that the psychological reactions may 
	depend strongly on what he is normally accustomed to see. Seeing a woman’s 
	naked breast will not normally produce any strong sexual arousal or 
	at­trac­tion among men living in a warm country where all women go with 
	their breasts un­co­vered throughout the year, while it may be completely 
	different in a cold country where all women normally go with their breasts 
	covered (for reasons of temperature regu­lation) most of the year. An 
	analogy might be seen to the phenomenon of phar­ma­co­lo­gical tolerance 
	de­velopment for opiate drugs. A drug addict who takes heroin every day will 
	need to en­hance the dose in order to obtain the desired effect. Then he 
	comes into a prison where he­roin is not avail­able, or he goes voluntarily 
	to an institution for treatment of his drug ad­dic­tion prob­­lem. 
	Everything is now good and well until that day when he is released from the 
	pri­son or leaves the treat­ment institution. He meets some of his old 
	friend, believes him­self that he is careful when taking con­si­derably less 
	than the dose he used to take before – but he underestimates the magnitude 
	of the drug tolerance effect (which has now dis­ap­pea­red during the long 
	period he has been completely without opiate drugs), and dies the­re­fore 
	soon after from what is now a serious overdose.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Such 
	considerations would presumably not affect the amount of clothes used by 
	small children during the summer. But it could have been of some importance 
	for the amount of clothes used during summer times by pre-puberty and early 
	puberty girls – at an age where vitamin D status is still very important for 
	ensuring normal de­ve­lop­ment of the pelvis (es­pe­cially during the growth 
	spurt of puberty). As far as the small children are concerned, it may be 
	understandable if their mothers did not want the small one to be ‘eaten up’ 
	by mos­qui­toes. Perhaps they may also have been thinking about the risk of 
	sna­ke bites. While a European viper’s bite is not normally much dangerous 
	for an adult person (the fa­ta­lity rate without treatment is low), it is 
	quite dif­fe­rent with a child only 2 or 3 years old.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Se­ri­ous 
	vitamin D deficiency will cause rachitis in children and osteomalacia in 
	adults.<a name="_ftnref50" title href="#_ftn50"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[50]</span></span></a> 
	One of the most serious con­se­quences of this disease is mal­formation 
	(flattening) of the pelvis in girl children, which increases the risk of 
	maternal and infant morbidity and mortality during.<a name="_ftnref51" title href="#_ftn51"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[51]</span></span></a> 
	Rachitis can also cause skeletal deformities in the lower limbs and severe 
	muscle weakness making it impossible for children to walk without support.<a name="_ftnref52" title href="#_ftn52"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[52]</span></span></a> 
	This must, of cour­se, also<i> </i>have been a very severe handicap for 
	nomadic hunter-gatherer peoples. It might be speculated if this problem 
	might have played some role in the earliest domestication of animals used 
	for riding (<i>e.g.</i> horses) or as draught animals pulling sledges or 
	pulks during the winter – <i>i.e.</i> that live animals may have been 
	cap­tu­red for the purpose of helping some­body who could not walk on his 
	own legs and also was a bit too heavy to be carried by other family members 
	over great distances. &nbsp;</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It may be 
	possible that the problem of vitamin D deficiency among hunter-gatherer 
	tribes living in northern and central parts of the Eurasian inland during 
	the Ice Age may have been compounded by the ef­fects of very high dietary 
	animal food/plant food ratios on urinary pH and urinary calcium excretion. 
	Low urinary pH is associated with enhanced urinary calcium excretion.<a name="_ftnref53" title href="#_ftn53"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[53]</span></span></a> 
	It is possible that this may be due to a com­bination of more than one 
	me­cha­nism acting both at the levels of bone tissue,<a name="_ftnref54" title href="#_ftn54"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[54]</span></span></a> 
	endocrine glands,<a name="_ftnref55" title href="#_ftn55"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[55]</span></span></a> 
	and more di­rect­ly in the kidneys. </span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The net 
	di­ur­nal urinary excretion of acids or alkalies is normally governed (if we 
	leave out of con­sideration clearly pa­tho­logical situations such as 
	diabetic ketosis) by the balance between so-called alkali-ash foods and 
	acid-ash foods in the diet.<a name="_ftnref56" title href="#_ftn56"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[56]</span></span></a> 
	Alkali-ash foods contain a surplus of me­tal­lic cations (such as potassium, 
	magnesium, sodium and calcium) over the acid-forming elements chlo­rine, 
	sul­fur and phosphorus, while acid-ash foods con­tain a surplus of 
	acid-forming elements over the me­tals, cal­cu­la­ted as equivalents of the 
	cor­responding acids and bases.<a name="_ftnref57" title href="#_ftn57"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[57]</span></span></a> 
	Much of the dietary intake of sulfur is in form of the sulfur amino acids 
	cysteine and methionine. However, when these are me­ta­bo­lically degraded, 
	sulfuric acid is formed as the quantitatively most important metabolic end 
	pro­duct. For mag­nesium and even more for calcium, it must be taken into 
	consideration that intestinal ab­sorb­tion is limited – and it is only the 
	amount absorbed by the intestine which is important for the body’s acid-base 
	budget (and hence for urinary pH). Most of the organic acids found in 
	ordinary foods (<i>e.g.</i> in various fruits) with ex­cep­tion of oxalic 
	acid and ascorbic acid (vi­tamin C) are almost completely metabolically 
	de­gra­ded; they will the­re­fore not affect the over-all acid-base balance.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Most animal 
	foods (such as meat, fish, offal and eggs) contain a large surplus of 
	acid-forming over base-forming elements; they are therefore typical acid-ash 
	foods.<a name="_ftnref58" title href="#_ftn58"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[58]</span></span></a> 
	&nbsp;</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">Fruits, ve­ge­tables and 
	plant tubers contain a surplus of alkali-forming elements, especially 
	potassium but also mag­nesium, and are therefore alkali-ash foods.<a name="_ftnref59" title href="#_ftn59"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[59]</span></span></a> 
	Cereals and other seeds have much lower K/energy and K/pro­tein ratios 
	compared with most fruits, berries, vege­tab­les and tubers, and the (total 
	me­tals)/protein and (total metals)/food energy ratios are even smaller in 
	refined than in unre­fined cereals.<a name="_ftnref60" title href="#_ftn60"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[60]</span></span></a> 
	Po­li­shed rice is an acid-ash food.<a name="_ftnref61" title href="#_ftn61"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[61]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The effects of 
	159 different retrojected preagricultural (hunter-gatherer) diets have been 
	calculated.<a name="_ftnref62" title href="#_ftn62"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[62]</span></span></a> 
	The calculations show that most of these hypothetical Paleolithic diets gave 
	a net surplus of bases (alkali-ash) and therefore would have produced a 
	neut­­ral or al­ka­line urine, in spite of protein intakes that were much 
	higher than is common today - in the ran­ge 135-259 g protein/day.<a name="_ftnref63" title href="#_ftn63"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[63]</span></span></a> 
	The explanation for the surplus of base in most of the ret­ro­jec­ted 
	Paleolithic diets was a much higher total consumption of alkali ash – mostly 
	in form of po­tas­sium - from plant foods than is common today.<a name="_ftnref64" title href="#_ftn64"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[64]</span></span></a> 
	The average net endogenous acid production for all 159 ret­ro­jec­ted diets 
	was –88 +/- 82 mEq/day - as against 48 mEq/day for the ave­ra­ge American 
	diet today.<a name="_ftnref65" title href="#_ftn65"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[65]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The effect of 
	mild metabolic acidosis and low urinary pH on urinary calcium ex­cre­tion is 
	very sub­stan­tial, as illustrated by an experiment where a group of 18 
	postmenopausal women were given a constant diet containing 625 mg of calcium 
	and 96 g of protein per 60 kg of body weight.<a name="_ftnref66" title href="#_ftn66"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[66]</span></span></a> 
	The effect of potassium bicarbonate supplementation nearly enough to 
	com­pletely neutralize the endogenous acid (60 to 120 mmol per day) was then 
	tested. Du­ring the ad­mi­nis­tra­tion of potassium bicarbonate, the calcium 
	and phosphorus balances were found to become less negative or more positive.<a name="_ftnref67" title href="#_ftn67"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[67]</span></span></a> 
	The average change in calcium ba­lance was 56 +/- 76 mg per day per 60 kg 
	body weight, while the average change in phos­phorus balance was 47 +/- 64 
	mg per day per 60 kg body weight.<a name="_ftnref68" title href="#_ftn68"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[68]</span></span></a> 
	It should be noted that one must eat much extra calcium (given the limited 
	intestinal calcium absorbtion) in order to compensate for an enhancement of 
	the urinary calcium excretion by 50 mg per day. It may therefore be 
	reasonable to con­clu­de that mild metabolic acidosis caused by a surplus of 
	acid ash over alkaline ash in the diet very plausibly might be regarded as 
	the single most im­por­tant cause of osteoporosis in the western world today 
	(even though there may be also other im­por­tant causal factors acting in 
	the same direction, such as a high dietary intake of so­di­um, which is 
	so­me­thing which we shall return to below).</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The 
	agricultural revolution was attended by a large enhancement of the 
	consumption of cereals at the expense of many of those foods that had been 
	consumed in greater quantity by Paleolithic hunter-gatherer po­pu­lations.<a name="_ftnref69" title href="#_ftn69"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[69]</span></span></a> 
	Even if the total protein intake and the con­sump­tion of animal pro­tein 
	foods was reduced, the total consumption of potassium-rich plant foods was 
	reduced even more, lea­ding to enhancement of the net en­do­genous acid 
	pro­duction. Today, it is also common over large parts of the world that 
	people eat mainly refi­ned cereal products (such as white wheat flour in 
	North America, Great Britain and France, and polished rice in the countries 
	of East Asia and Southeast Asia), as well as much sugar and edible fats and 
	oils. These diets rich in energy-rich and refined foods will com­mon­ly give 
	a surplus of endo­ge­nous acid production, even when the total protein 
	con­sump­tion and the consumption of ani­mal protein both are much lower 
	than was com­mon for Paleo­lithic hunter-gatherer popu­la­tions.<a name="_ftnref70" title href="#_ftn70"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[70]</span></span></a> 
	The result of this will be a mild metabolic acidosis (<i>i.e.</i> the 
	average pH of blood plasma will be slightly lower than was common during the 
	Paleolithic) and acidic urine, which will not be asso­cia­ted with 
	en­han­ced risk of osteo­po­ro­sis, but also may have other adverse health 
	con­se­quences inclu­ding an enhanced tendency for tissue protein loss which 
	may lead to reduc­tion of the ske­le­tal muscle mass, and en­han­ced risk of 
	kidney stone for­ma­tion.<a name="_ftnref71" title href="#_ftn71"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[71]</span></span></a> 
	Furthermore, it may also be spe­cu­la­ted that even a mild metabolic 
	acidosis may be enough to contribute to enhanced activation of 
	pain-conducting nerve fibers because of activation of so-called vanilloid 
	receptors (also called capsaicin receptors); these re­cep­tors are sensitive
	<i>i.a. </i>to low pH,<a name="_ftnref72" title href="#_ftn72"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[72]</span></span></a> 
	noxious heat,<a name="_ftnref73" title href="#_ftn73"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[73]</span></span></a> 
	the endogenous cannabinoids anan­da­mide (<i>N</i>-arachidonoyl-ethanolamine) 
	and 2-ara­chi­do­no­ylglycerol (2-AG)<a name="_ftnref74" title href="#_ftn74"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[74]</span></span></a> 
	and fatty acid hyd­ro­per­oxi­des and hydroxides pro­du­ced by the 
	12-lipoxygenase and 15-lip­oxy­ge­na­se path­ways,<a name="_ftnref75" title href="#_ftn75"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[75]</span></span></a> 
	as well as by leukotriene B<sub>4</sub>.<a name="_ftnref76" title href="#_ftn76"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[76]</span></span></a> 
	They are also sen­si­ti­ve to capsaicin,<a name="_ftnref77" title href="#_ftn77"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[77]</span></span></a> 
	which is the ‘burning’ sub­stan­ce found in red pepper.<a name="_ftnref78" title href="#_ftn78"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[78]</span></span></a></span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It has been 
	found that the degree of acidosis in modern, ‘westernised’ populations also 
	has a tendency to increase with age.<a name="_ftnref79" title href="#_ftn79"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[79]</span></span></a> 
	It may be possible that this is not only a con­se­quence of changes in total 
	food intake or average diet compo­si­tion as a function of age, but also may 
	happen as a result of loss of mitochondrial capacity, partly as a result of 
	normal mitochondrial aging<a name="_ftnref80" title href="#_ftn80"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[80]</span></span></a> 
	and partly because of re­duc­tion of the level of physical activity. The 
	re­duction of mitochondrial capacity might be associated with a ten­den­cy 
	for enhanced me­tabolic lactic acid production even under resting conditions 
	(and also at any level of physical activity) which in turn might be 
	associated with en­han­cement of the ave­rage con­cen­tration of lactic acid 
	in blood plasma (<i>i.e.</i> mild lactic acidosis) and en­han­ced urinary 
	excretion of lactic acid. It may theo­re­tically be expected that this 
	problem may be enhanced by any toxic agent (<i>e.g.</i> carbon monoxide, 
	various toxic heavy metals) and any dietary deficiency con­dition (<i>e.g.</i> 
	thia­mine deficiency, copper deficiency) that may con­tri­bute to inhibition 
	of mi­to­chondrial function. The risk of such deficiencies (especially 
	sub­cli­nical ones) will, of course, be enhanced when people eat much “empty 
	calories”, <i>i.e.</i> food which contain little or no water-soluble 
	vitamins, essential trace ele­ments, potassium and mag­ne­si­um, as wes­tern 
	populations com­monly do. It should be noted that impairment of 
	mito­chond­rial func­tion <i>e.g.</i> in skeletal muscle also must be 
	expected to enhance the risk of local aci­dosis that in turn may 
	con­tri­bu­te to activation of vanilloid receptors and hence to the 
	oc­cur­rence of chro­nic or in­ter­mittent muscular pain.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It may be 
	expected that a more carbohydrate-rich diet will enhance the net metabolic 
	lactic acid pro­duction, other factors being equal. A diet rich in refined 
	carbohydrates may thus have a double detrimental action because it enhances 
	the risk of dietary deficiency con­ditions that cause inhibition of 
	mitochondrial func­tion (<i>e.g.</i> copper deficiency, thiamine 
	de­fi­­ciency) at the same time as it also enhances the substrate load for 
	metabolic conversion of glucose (blood sugar) to lactic acid. This may, for 
	reasons already explained (en­han­ced va­nilloid receptor activation), very 
	likely also contribute to enhancement of chronic pain prob­lems <i>e.g.</i> 
	localized to parts of the skeletal muscles. It might be added that adipose 
	tissue is reported to have a high ca­pa­city for lactic acid production, 
	which is enhanced in patients with type 2 diabetes and some of their 
	first-deg­ree relatives.<a name="_ftnref81" title href="#_ftn81"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[81]</span></span></a> 
	It may therefore be possible that obe­si­ty also may be an important factor 
	tending to enhance the total level of lactic acid pro­duc­tion (for a given 
	diet composition and a given level of phy­si­cal activity).</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood plasma 
	levels of lactic acid are, furthermore, also enhanced by alcohol (which 
	happens as a consequence of the effect of alcohol degradation on the liver 
	cell [NADH]/[NAD<sup>+</sup>] concentration ratio, cau­sing enhancement of 
	the lactate/pyruvate ratio in the liver);<a name="_ftnref82" title href="#_ftn82"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[82]</span></span></a> 
	this may in turn help to explain the connection between alcohol con­sumption 
	and gout (caused by deposition of crystals of uric acid in some of the 
	joints)<a name="_ftnref83" title href="#_ftn83"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[83]</span></span></a> 
	since high concentrations of lactate in serum will inhibit the urinary 
	ex­cre­tion of uric acid.<a name="_ftnref84" title href="#_ftn84"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[84]</span></span></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
	While modern man has much lower average potassium consumption than was 
	com­mon among Pa­leo­­­lithic hunter-gatherer populations,<a name="_ftnref85" title href="#_ftn85"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[85]</span></span></a> 
	he has on the other hand much higher average sodium consumption, mainly from 
	table salt (NaCl), but also from sodium bicar­bo­na­te used in many bakery 
	products. A high intake of sodium will lead to cor­res­pon­ding enhancement 
	of the urinary ex­cre­tion of sodium (since sodium is very well ab­sor­bed 
	in the intestine). This, however, will also lead to enhan­cement of the 
	urinary excretion of cal­cium.<a name="_ftnref86" title href="#_ftn86"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[86]</span></span></a> 
	This is most probably because high levels of urinary sodium cause inhibition 
	of the tubular reabsorbtion of cal­cium.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For people who 
	live on typical modern diets, it must the­re­fo­re be expected that high 
	intakes of so­di­um and a surplus of acid-ash over alkaline-ash foods both 
	will interact with each other in an additive or syn­ergistic factor, leading 
	to enhancement of the urinary ex­cre­tion of cal­ci­um. The limited 
	absorbtion of calcium in the intestine can make it difficult to compensate 
	for this en­han­ce­ment of urinary calcium excretion, even at huge dietary 
	calcium intakes. But it will, of course, be even more difficult to 
	compensate for high urinary cal­ci­um losses if vitamin D status is marginal 
	or if vitamin D con­ver­sion to ‘vitamin D hor­mo­ne’ 
	(1,25-di­hyd­ro­xycholecalciferol) is inhibited <i>e.g.</i> because of high 
	burdens of toxic heavy metals, such as cadmium, lead and most probably also 
	mercury. It has been shown both in animal expe­ri­ments and epidemiologic 
	studies that to­xic heavy metals such as cadmium and lead affect the 
	con­ver­sion of vitamin D to 1,25-di­­hyd­ro­xy­cho­le­cal­ci­fe­rol.<a name="_ftnref87" title href="#_ftn87"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[87]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cadmium, 
	mercury and lead may, moreover, also inhibit active membrane transport of 
	calcium,<a name="_ftnref88" title href="#_ftn88"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[88]</span></span></a> 
	which is one of the pro­ces­ses stimulated by 
	1,25-di­hyd­ro­xy­cho­le­cal­ciferol when this hor­mones promotes the 
	intes­ti­nal ab­sorb­tion of calcium.<a name="_ftnref89" title href="#_ftn89"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[89]</span></span></a> 
	High-level lead expo­su­re has also been re­por­ted to to block the 
	stimu­la­ting effect of 1,25-dihyd­ro­xy­cho­le­cal­ci­fe­rol on intes­tinal 
	calcium ab­sorb­tion in ex­pe­rimental animals.<a name="_ftnref90" title href="#_ftn90"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[90]</span></span></a>
	</span><span lang="EN-GB">And mercury</span></font><span lang="EN-GB" style="font-family: Times New Roman"><a name="_ftnref91" title href="#_ftn91"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: Verdana">[91]</span></span></a></span><font face="Verdana"><span lang="EN-GB">
	</span><span lang="EN-GB" style="font-family: CG Times">and cadmium<a name="_ftnref92" title href="#_ftn92"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[92]</span></span></a> 
	have both been reported to en­hance the urinary excretion of calcium, 
	presumably by in­hi­bi­ting calcium reabsorbtion in the renal tubuli.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is on this 
	background not much surprising that high en­vi­ron­men­tal cadmium 
	ex­po­sure has been re­por­ted to be asso­cia­ted with enhanced incidence of 
	osteporosis,<a name="_ftnref93" title href="#_ftn93"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[93]</span></span></a> 
	or that post­­me­no­pau­sal os­teo­po­rosis is more common among smo­king 
	women than among non-smo­kers,<a name="_ftnref94" title href="#_ftn94"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[94]</span></span></a> 
	given the im­por­tance of tobacco smoke as a source of cadmium<a name="_ftnref95" title href="#_ftn95"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[95]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How mer­cu­ry 
	affects the con­ver­sion of vi­ta­min D to 
	1,25-di­hyd­ro­xy­cho­lecalciferol appears not to have been much studied, if 
	at all, either expe­ri­men­tal­ly or epi­de­mio­logically, but gi­ven the 
	im­por­tant chemi­cal simi­la­rities between these three elements, it would 
	be very sur­pri­sing if mer­cury should not have a similar effect as has 
	been earlier de­mon­strated both for cadmium and lead. Nor seems there to 
	have been much re­search interest for the ques­tion, how mercury loads <i>
	e.g.</i> from dental amalgam fillings may affect the long-term calcium 
	balance and risk of osteoporosis. It has been reported from a study in 
	Japan, however, that the mercury concentrations in hair were considerably 
	higher in patients suffering from os­teo­­porosis, compared to normal 
	controls.<a name="_ftnref96" title href="#_ftn96"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[96]</span></span></a> 
	The same was also found in patients suffering from several other ordinary 
	diseases, such as atopic dermatitis, dementia, cerebral infarct, 
	hypertension and diabetes.<a name="_ftnref97" title href="#_ftn97"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[97]</span></span></a> 
	This could perhaps be taken as an indication that mercury and also other 
	toxic heavy metals such as cadmium and lead may play a much more important 
	role as etiological factors (con­tri­bu­tory causes) in several 
	non-infec­ti­ous ordinary diseases than hitherto has been realized.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; From what has 
	been explained above, it must be expected that toxic heavy metals and a 
	surplus of acid-ash foods over alkaline-ash foods in the diet most likely 
	may interact with each other in strongly syn­ergistic fashion as causes of 
	osteoporosis. Both factors are likely to play a more than negligible role, 
	even when acting alone, but the total effect must be expected to be larger 
	than for a simple additive interaction when both are present 
	simul­ta­neously – which they could be for more than 50% of the total 
	population in a country such as Norway. There may perhaps not be so much 
	reason to wonder, after all, why there should be so much osteoporosis in 
	Oslo, causing the city to lie near the top of the inter­na­tional 
	sta­tis­tical ranking list, as regards the (age-corrected) incidence of 
	femoral fracture among the elderly.<a name="_ftnref98" title href="#_ftn98"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[98]</span></span></a></span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Even if most of 
	the retrojected diets of Sebastian <u>et al</u>.<a name="_ftnref99" title href="#_ftn99"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[99]</span></span></a> 
	&nbsp;had a surplus of alkali ash, which would be expected to lead to low rates 
	of urinary calcium excretion, it may be pos­sible that many hunter-gatherer 
	peop­les living under conditions of Arctic or sub-Arctic climate may have 
	subsisted on diets even more ex­tre­me than the most extreme cases studied 
	by Sebastian <u>et al</u>.<a name="_ftnref100" title href="#_ftn100"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[100]</span></span></a> 
	This is because po­tas­sium-rich plant foods tend to become 
	pro­gres­si­ve­ly less abundant and less availability, compared to the 
	abundance and availability of ani­mal foods, as climatic conditions become 
	more extreme. One of the most important reasons for this is that most of the 
	plant foods concerned can be gathered only during the summer half of the 
	year, and sometimes only during a short part of the summer or autumn seasons 
	(<i>e.g.</i> lin­gon­ber­ries).&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There is much 
	qualitative information available about the diets of several sub-Arctic and 
	Arctic peop­les (in northern Europe, northern Asia, northern America and 
	Greenland) over the last few centuries, but for many of them not so much 
	quan­titative data.<a name="_ftnref101" title href="#_ftn101"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[101]</span></span></a> 
	It is evi­dent that all of them have sub­sis­ted not only on animal foods, 
	but also on several kinds of plant foods including berries of various kinds, 
	green leafy vegetables (<i>e.g. Angelica arch­an­gelica</i>), and edible 
	root tubers (<i>e.g.</i> from <i>Polygonum</i> species, so-called ‘Esquimo 
	po­ta­toes’).<a name="_ftnref102" title href="#_ftn102"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[102]</span></span></a> 
	In areas with forest (<i>e.g.</i> in Swedish Lapland), people have also been 
	eating the cambium from certain trees (in form of so-called bark bread) not 
	only as emergency food, but also as normal food.<a name="_ftnref103" title href="#_ftn103"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[103]</span></span></a> 
	Stomach contents from reindeer and intestinal contents from grou­­­ses have 
	also been eaten (even among peop­les who had a taboo against eating grouse 
	meat because its taste was said to be too similar to that of meat from 
	humans),<a name="_ftnref104" title href="#_ftn104"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[104]</span></span></a> 
	and in some of the most extreme climatic situa­tions even faeces from 
	grouses.<a name="_ftnref105" title href="#_ftn105"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[105]</span></span></a> 
	These (for us) unusual foods may not only have func­tioned as good sources 
	of alkali ash, but also as sour­ces of mineral nutrients such as manganese 
	and boron which are found only in very low concentrations in practically all 
	animal foods.<a name="_ftnref106" title href="#_ftn106"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[106]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The possibility 
	can on this background not be excluded that even some of those peop­les who 
	were living under sub-Arctic conditions may have eaten enough plant foods to 
	give a neutral or alkaline urine. However, it is more reasonable to believe 
	that most of them must have had acidic urines through­out most of the year - 
	with exception of those seasons when berries etc. were most abundantly 
	avail­able. But two or three months (perhaps) with alkaline urine and low 
	urinary calcium excretion would not be enough to compensate for the effect 
	of 9 or 10 months with acidic urine and correspondingly high urinary calcium 
	ex­cre­tion (which, however, might be mitigated by much lower salt 
	consumption than is common in modern populations). For many of the 
	hunter-gatherer peoples who were living under conditions of Arctic or 
	sub-Arctic climate in Eu­­ro­pe and Asia during the Ice Age, it may thus be 
	possible that the problem of marginal vitamin D supply or outright 
	deficiency may have been compounded by a surplus of acid-ash foods over 
	alkaline-ash foods leading to enhancement of the urinary excretion of 
	calcium.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The development 
	of the pelvis in girl children may be especially vulnerable to defi­ci­ency 
	of vitamin D during the growth spurt of puberty. If the opening of the 
	pelvis became much too narrow because of child­hood ra­chitis, it is 
	probable that this may during the Stone Age often have made it impossible 
	for young wo­men to give birth to live children and also survive them­selves 
	without Caesarean delivery. Caesarean delivery, however, was rarely 
	practised even as late as in Europe during the early nineteenth century and 
	was then con­si­dered highly dangerous, being both technically and morally 
	controversial.<a name="_ftnref107" title href="#_ftn107"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[107]</span></span></a> 
	In spite of this, it is not unreasonable to think that Stone Age people who 
	were living in areas with much pelvic de­for­mities because of rickets often 
	may have tried to perform Cae­­sarean sec­tion. This is because they may 
	have understood this was the only possible way if they should try to save 
	both the mother and the child, and the possibility that the child would 
	survive may have been pretty good even if the death risk for the mother was 
	probably often very high. It is reasonable to expect that mor­ta­li­ty 
	fol­lowing this procedure often would have been high <i>i.a.</i> be­cau­se 
	very low human po­pu­lation den­si­ties on the tundra may have prevented 
	rapid horizontal diffusion of know­ledge about the best pro­cedure helping 
	to pre­­vent the mo­ther dying from hemorrhage (and sometimes from 
	infection) shortly after­wards; there was pro­bably no­thing comparable to a 
	mo­dern me­di­cal school those days and no ‘tundra medical aca­de­my’.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is not 
	difficult to understand that this problem must have constituted a strong 
	evo­lutionary force; the evolutionary consequences will, of course, be the 
	same if mother and child die during childbirth or if a woman understands 
	that she must never have children, if she shall have any hope of reaching 
	high age her­self. Anything that may help to reduce this problem will thus 
	be selected for; this may not only be the case in the classic evolu­tio­nary 
	sense with genetic properties (such as alleles for light skin colour), but 
	may also apply to cultural practices or habits because groups that had 
	started with practices that increased the sur­vi­val chances for their women 
	during childbirth (<i>e.g.</i> coastal peoples eating cod liver, tundra 
	hunting peoples consuming rein­deer milk, lear­ning how to perform Caesarean 
	sec­tion as safely as possible) would also have more sur­vi­ving offspring 
	com­pa­red to groups that did not have the same positive-survival-value 
	customs. Among pos­sib­le dietary sources of vitamin D, one might wonder if 
	liver from bears or other omnivore or carnivore species possibly might have 
	played a role and if this may be one of the reasons for the common 
	etymologies of words having to do with childbirth and human reproduction and 
	the name of the animal species bear on the other side. Was bear liver 
	something that was eaten by girl children in order that they should be able 
	to give birth the normal way and not die during childbirth as soon as they 
	became adult young women?</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dark skin 
	colour can be regarded as an evolutionary adaptation helping to protect 
	people li­ving at lo­wer latitudes against damage resulting from too much 
	ultraviolet radia­tion, such as acceleration of de­ge­ne­ra­tive aging 
	processes in the skin,<a name="_ftnref108" title href="#_ftn108"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[108]</span></span></a> 
	skin cancer,<a name="_ftnref109" title href="#_ftn109"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[109]</span></span></a> 
	and – perhaps most important during the Stone Age – <b>immu­no­de­pression
	</b>which is caused by a combination of different mechanisms.<a name="_ftnref110" title href="#_ftn110"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[110]</span></span></a> 
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sunlight is res­pon­sible for wrinkling, blotching, drying, and 
	lea­the­ring of skin, and it is es­ti­ma­ted that 90% of all skin cancers 
	result from long-term exposure to ult­ra­vio­let radiation.<a name="_ftnref111" title href="#_ftn111"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[111]</span></span></a> 
	Skin cancer is the most common malignancy in man, with an in­ci­dence of 1 
	million new cases diagnosed in the United States in 1999.<a name="_ftnref112" title href="#_ftn112"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[112]</span></span></a> 
	So­lar radiation is a well documented risk factor both in melanoma and non 
	melanocytic skin cancer, <i>i.e.</i> basal cell and squamous cell carcinoma.<a name="_ftnref113" title href="#_ftn113"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[113]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UV light may 
	also cause photochemical degradation of folate,<a name="_ftnref114" title href="#_ftn114"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[114]</span></span></a> 
	which may in turn lead to folate de­fi­ciency, especially when the dietary 
	intake of this vitamin is marginal (which is very common today, but may not 
	have been so common among Paleolithic hun­ter/gatherer populations as long 
	as their total intake of food was adequate). It has been found that exposure 
	of human blood plasma <i>in vitro</i> to simulated strong sunlight caused 30 
	to 50 percent loss of folate within 60 minutes.<a name="_ftnref115" title href="#_ftn115"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[115]</span></span></a> 
	Fur­ther­mo­re, light-skinned patients ex­po­sed to ultraviolet light for 
	derma­to­logic disorders have ab­normally low serum folate con­cen­trations 
	(if they do not take folate supplements at an ade­quate dosage level), 
	sug­ges­ting that photolysis may also occur <i>in vivo</i>.<a name="_ftnref116" title href="#_ftn116"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[116]</span></span></a> 
	&nbsp;</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Folate 
	deficiency, which oc­curs in many marginally nourished populations, may 
	cau­se severe ane­mia, neural tube defects and other con­ge­nital 
	malformations, frank infer­ti­li­ty, and maternal mortality.<a name="_ftnref117" title href="#_ftn117"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[117]</span></span></a> 
	It has been proposed that prevention of ult­ra­vio­let pho­to­ly­sis of 
	folate and other light sensitive nutrients by dark skin could be sufficient 
	explanation for the maintenance of this characteristic in groups of humans 
	living in regions with intense solar radiation.<a name="_ftnref118" title href="#_ftn118"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[118]</span></span></a> 
	&nbsp;</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An ob­jec­tion 
	against this hypothesis is that the diets of Paleo­lithic hun­ter/gatherer 
	populations may typically have been of much better quality than diets common 
	today both in de­ve­loping and industrial coun­tries;<a name="_ftnref119" title href="#_ftn119"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[119]</span></span></a> 
	this may also have been the case with the diets of some of the Stone Age 
	far­mers or horticulturalists, as exemplified by the diet on the island of 
	Ki­ta­va, which is one of the Trobriand Islands in Papua New Guinea.<a name="_ftnref120" title href="#_ftn120"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[120]</span></span></a> 
	Pa­leo­li­thic man may ty­pi­cal­ly have ingested much more mic­ro­nutrients 
	in­cluding folate than is common among im­po­ve­rished popu­la­tions living 
	in regions with intense solar radiation today.<a name="_ftnref121" title href="#_ftn121"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[121]</span></span></a> 
	This may in turn have helped to reduce his vulnerability to deficiency 
	dis­or­ders caused by pho­to­che­mical de­gra­dation of folate and other 
	UV-sensitive nutrients in the skin.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It may be 
	possible that the decrease of folate intakes, comparing Paleolithic diets 
	with diets today, may be one of those dietary changes which most critically 
	have affected the health of large groups of people both in industrial and 
	poor countries. There may be reason to look closer at some of the 
	consequences in relation to current health problems and explain why it is 
	not only the health of our generation, but also the health of future 
	gene­ra­tions that here may be at stake.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Folate 
	deficiency is a common cause, or contributory cause (in combination with 
	ge­ne­tic dis­tur­ban­ces), of hyperhomocysteinemia, which in turn is 
	strongly associated with en­hanced risk of cardiovascular dis­ease and 
	enhanced cardiovascular mor­ta­lity.<a name="_ftnref122" title href="#_ftn122"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[122]</span></span></a> 
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Moreover, folate deficiency may also cause im­pair­ment of 
	im­mu­nological func­tions.<a name="_ftnref123" title href="#_ftn123"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[123]</span></span></a> 
	Cell-mediated immunity is especially affected by folate deficiency: the 
	blastogenic response of T lymphocytes to cer­tain mitogens is decreased in 
	folate-deficient humans and animals, and the thymus is al­te­red.<a name="_ftnref124" title href="#_ftn124"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[124]</span></span></a> 
	Folate deficiency must therefore be ex­pected to con­­­tri­bu­te to enhanced 
	morbidity and mortality from infectious diseases, es­pe­cially when also the 
	dietary intake of DNA simultaneously is low, as it usually will be in 
	patients with a low total intake of dietary protein. This is be­cau­se a 
	good immunological response depends on a ra­pid proliferative response in 
	various types of leukocytes or their precursors, which is not possible 
	without correspondingly high rates of DNA synthesis in the pro­li­fe­ra­ting 
	cells. The effects of folic acid deficiency upon hu­mo­ral immunity have 
	been more thoroughly in­ves­ti­ga­ted in animals than in humans, and the 
	antibody responses to several antigens have been shown to decrease.<a name="_ftnref125" title href="#_ftn125"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[125]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For DNA 
	synthesis to occur, it is necessary that there is an adequate supply of all 
	of those four nuc­leotides (in form of the corresponding triphosphates) that 
	are found in the DNA molecule. The genetic mes­sa­ge is written in the DNA 
	molecule in form of long ‘words’ (corresponding to different genes) that are 
	written with four ‘letters’, corresponding to four different nucleotide 
	bases.<a name="_ftnref126" title href="#_ftn126"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[126]</span></span></a> 
	During transcription, parts of the DNA molecules are co­pied to form 
	corresponding RNA molecules.<a name="_ftnref127" title href="#_ftn127"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[127]</span></span></a> 
	These contain three of the same ba­ses as the DNA molecules, while bases 
	number four are different in the DNA and RNA mo­le­cu­les, being uracil in 
	RNA and thymine in DNA.<a name="_ftnref128" title href="#_ftn128"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[128]</span></span></a> 
	RNA and DNA also contain two different sugars, with RNA containing ribose 
	while DNA contains deoxyribose.<a name="_ftnref129" title href="#_ftn129"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[129]</span></span></a></span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During 
	synthesis of DNA and RNA, it is necessary that the nucleotide bases are 
	avail­able in form of the corresponding nucleotides which, furthermore, must 
	be trans­for­med into the corresponding energy-rich triphosphates before 
	they can be incor­porated into DNA or RNA molecules.<a name="_ftnref130" title href="#_ftn130"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[130]</span></span></a> 
	Nuc­leotides used during DNA and RNA biosynthesis can be made in two 
	different ways, either by <i>de novo</i> path­ways from precursor molecules 
	that do not con­tain nucleotide bases, or by so-cal­led salvage pathways 
	from de­gradation products of DNA and RNA (which may come from dead human 
	cells, from the diet, or from bac­teria and other microorganisms <i>e.g.</i> 
	in the intestine), so that purine and pyrimidine bases from de­graded DNA 
	and RNA molecules can be used once more to form new DNA or RNA.<a name="_ftnref131" title href="#_ftn131"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[131]</span></span></a> 
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Folate participates in the <i>de novo</i> biosynthetic pathways for 
	three of the four dif­fe­rent nucleotides found in DNA molecules, viz. the 
	purine base-containing nucleotides de­oxy­adenylate and deoxyguanylate and 
	the pyrimidine base-containing nucleotide thy­mi­dy­late.<a name="_ftnref132" title href="#_ftn132"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[132]</span></span></a> 
	It also participates in the <i>de novo</i> bio­synthetic pathways for the 
	purine base-con­tai­ning nucleotides adenylate and guanylate which are used 
	during RNA biosynthesis.<a name="_ftnref133" title href="#_ftn133"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[133]</span></span></a> 
	Du­ring <i>de novo </i>thymidylate biosynthesis, folate par­ti­cipates as an 
	essential component of the enzyme thy­mi­dylate synthase, which makes 
	thy­mi­dylate from deoxyuridylate.<a name="_ftnref134" title href="#_ftn134"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[134]</span></span></a> 
	During <i>de novo</i> biosynthesis of the purine nucleotides (adenylate, 
	gua­ny­late, deoxyadenylate and de­oxy­­gua­ny­la­te), folate participates 
	as an essential com­po­nent of two different en­zy­mes ca­ta­ly­zing two 
	consecutive steps in the same pathway, <i>viz.</i> GAR transformylase (also 
	ab­bre­via­ted GART) and AICAR transformylase.<a name="_ftnref135" title href="#_ftn135"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[135]</span></span></a> 
	These folate-de­pen­dent steps in <i>de novo</i> pathways for biosynthesis 
	of nuc­leo­tides nee­ded for DNA and RNA biosynthesis are in­hi­bited by the 
	an­ti-cancer drug me­thotrexate, which functions as a folate antagonist.<a name="_ftnref136" title href="#_ftn136"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[136]</span></span></a> 
	This may at least in part help to explain the anti-cancer action of this 
	drug. It should be noted, however, that the same nucleotides that are needed 
	for DNA bio­syn­the­sis are also needed during DNA repair. It must therefore 
	be expected that metho­trexate will inhibit DNA repair in the tumor cells, 
	which may in turn enhance the pro­ba­bi­li­ty of severe DNA damage 
	triggering apoptosis (cel­lular suicide) in the tumor cell po­pu­la­tion.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It should also 
	be noted that nucleotides are needed during cell growth not only becau­se 
	they are nee­ded as precursors for making DNA and RNA, but also because they 
	par­ti­ci­pate in biosynthetic pathways for various mem­bra­ne lipids (<i>e.g.</i> 
	for making phos­pha­ti­dyl­choline from free choline) and carbohydrate 
	molecules.<a name="_ftnref137" title href="#_ftn137"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[137]</span></span></a> 
	Adenylate, furthermore, is also needed for making ATP, which is the chief 
	‘ener­gy cur­ren­cy’ molecule used by the cells to drive a large number of 
	different non-spontaneous che­mi­cal reac­tions including DNA and RNA 
	synthesis.<a name="_ftnref138" title href="#_ftn138"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[138]</span></span></a> 
	It is therefore easy to understand why cell growth processes will be slowed 
	down or stop altogether if they contain too little of one or more of those 
	nuc­leotides that are needed for energy metabolic and biosynthetic pathways 
	essential for cell growth. This may not only apply to cellular di­vi­sion, 
	but also other forms of cellular growth as it may be observed in 
	non-dividing musc­le cells or nerve cells, <i>e.g.</i> during the growth of 
	the infant brain, during regeneration pro­ces­ses following brain trauma or 
	stroke, and quite generally during learning processes (which may depend on 
	micro-anatomical re­mo­delling processes improving the synaptic con­tact 
	between particular pairs of neurons while perhaps also decreasing the 
	synaptic con­tact between other pairs of neurons). How­ever, it may be 
	expected that processes de­pen­ding on rapid cellular growth – which 
	includes various immunological functions and also the re­ge­neration of the 
	intestinal mucosa - may be es­pe­ci­al­ly sensitive to nucleotide 
	de­ple­tion.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The functional 
	disturbances that may occur as a consequence of folate deficiency will, 
	however, not depend only of the degree of folate deficiency. They will also 
	depend on the dietary intake of nucleotides and other nutrients which can be 
	made endogenously by <i>de novo</i> pathways dependent on folate. For the 
	same degree of folate deficiency, it must be expected that DNA and RNA 
	biosynthesis will be more severely af­fec­ted if the dietary intakes of DNA 
	and RNA are low than if they are high. The same may presumably also be the 
	case with processes of DNA repair. This is because more nuc­leo­tides can be 
	produced by salvage path­ways when the dietary intakes of DNA and RNA are 
	high than if when are low.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DNA and RNA 
	will always follow protein in the diet (with the probable exception of some 
	highly refined protein-rich food products such as surimi). A general 
	positive cor­re­lation will thus exist between the dietary intake of protein 
	and the dietary intakes of DNA and RNA. It must therefore be expected that 
	poor people in developing countries who have low total intakes of dietary 
	protein most commonly will have low dietary intakes of DNA and RNA as well. 
	This may in turn be expected to make them much more vulnerable to folate and 
	also vitamin B<sub>12</sub> deficiency, compared to more affluent people 
	living in the in­dus­trial countries (who can afford to buy more 
	protein-rich foods, especially in form of animal products, and therefore 
	will ingest more DNA and RNA as well). But the average protein intakes may 
	be much lower, even in many of the affluent industrial countries, compared 
	to the diets of many of other Paleolithic hunter-gatherer ancestors.<a name="_ftnref139" title href="#_ftn139"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[139]</span></span></a> 
	Model calculations on the com­po­si­tions of a large numbers of Paleolithic 
	model diets in order to estimate their effects on the acid-base balance 
	showed a range of protein intakes from about 135 g pro­te­in/day to 259 g 
	protein/day<a name="_ftnref140" title href="#_ftn140"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[140]</span></span></a> 
	- and it is possible that the daily protein intake may have been even higher 
	for some of the hun­ter/ga­therer peoples who were living in sub-Arctic or 
	Arctic en­vi­ronments (<i>e.g.</i> inland Inuits in Alaska until some 50-60 
	years ago, to mention a recent example). It may thus be expected that also 
	the daily intakes of DNA and RNA typically may have been much higher with 
	Paleolithic diets than is com­mon today, even for popu­la­tions living in 
	affluent western industrial societies.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The DNA/protein 
	and RNA/protein ratios are not the same in all types of food. The 
	DNA/protein ratio depends on the density of cell nuclei, mitochondria and 
	chloroplasts in the tissue or organ concerned, while the RNA/protein ratio 
	presumably will depend on the rate of protein turnover, being therefore 
	higher in organs with high capacity for protein biosynthesis such as for 
	instance the pancreas, the liver and the testes. It may be expected that 
	plant foods rich in storage protein (<i>e.g.</i> cereal grains) most 
	probably will have lower DNA/protein and RNA/protein ratios compared with 
	green lea­ves, which are functionally much more active, and also compared 
	with most animal foods. Many refined, ener­gy-rich foods (<i>e.g.</i> 
	refined sugar, margarine) are virtually empty both of DNA and RNA. It is 
	the­refore probable that the proportionate decline of nucleic acid intakes 
	must have been greater than for protein, comparing typical Paleolithic diets 
	with diets typical of the western indus­trial countries today. The decline 
	of DNA and RNA intakes may probably have started al­rea­dy with the Stone 
	Age agricultural revolution, but may have been greatly accentuated by 
	dietary changes that have occurred over the last 100-200 years with greatly 
	enhanced con­sumption of various refined car­bo­hyd­rate foods and edible 
	fats and oils simultaneously as the average <i>per capita</i> food energy 
	consumption has decreased as a result of decreased physical activity. 
	Another factor that may possibly also have acted in the same direc­tion, 
	especially as far as the intake of DNA is concerned, is reduced consumption 
	of various visceral organs such as heart, liver, lungs, brain, etc.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; At the same 
	time, it may also be possible that poverty – as it occurs in many 
	deve­lo­ping countries – often may be accompanied by proportionate 
	reductions of the intakes of RNA and DNA which may be even larger than the 
	relative reductions of protein intake, compared to diets typical of the 
	affluent countries and al­so compared to diets typical of the more affluent 
	socio-economic groups in the developing countries them­sel­ves.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It follows that 
	the deleterious effect of a certain degree of folate deficiency in rela­tion 
	to processes dependent on rapid cellular proliferation (including 
	immunological func­tions and also regeneration of the intestinal mucosa) 
	must be expected to be more serious when it affects people who because of 
	poverty have low dietary intakes of nucleic acids than when a similar degree 
	of folate deficiency affects people who are more affluent and there­fore can 
	afford to eat more of such foods that are good sources both of protein and 
	nucleic acids. The same may also be the case with dietary deficiency of 
	vitamin B<sub>12</sub> (because of the close biochemical collaboration 
	between folate and vitamin B<sub>12</sub>). On the other hand, it must also 
	be expected that the functional consequences of a given degree of folate 
	deficiency (<i>e.g.</i> because of rapid photochemical de­gra­dation of 
	folate in the skin) would have been smaller for people who were living on 
	Paleolithic diets than for most people subsisting on modern diets. It must 
	be expected that the combination of folate (or vitamin B<sub>12</sub>) 
	deficiency and low dietary intakes of DNA and RNA must lead to impairment of 
	im­mu­nological defense against virtually any kind of infectious disease 
	(even though it may be possible that the replication of the in­fec­tious 
	agent sometimes also might be inhibited as a result of nucleotide 
	defici­en­cies, es­pe­cially perhaps in the case of various viral 
	infections). At the same time, it may also be possible that it com­mon­ly 
	may lead to (or contribute to) degeneration of the intes­ti­nal mucosa 
	(villus atrophy), with the com­bi­na­tion of intestinal mucosal damage and 
	im­pai­red immunological functions in the intestine both con­tri­bu­ting to 
	increased mor­bi­dity and mortality from gastrointestinal infections.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Another 
	important question is what may be the possible consequences of nucleotide 
	deficiencies (because of the combination of low intakes of folate and/or 
	vitamin B<sub>12</sub> on one side and low dietary intakes of DNA and RNA on 
	the other) for DNA repair pro­ces­ses – and what consequences inefficient 
	DNA repair in turn might have both for the incidence of can­cer and for 
	biological aging. One might wonder how much in­hi­bition of DNA repair 
	(because of a poor diet) could mean <i>e.g.</i> for the problem of liver 
	cancer in many de­ve­lo­ping countries. And is it possible that smoking and 
	alcohol abuse both might be even more dan­ge­rous – as a consequence of less 
	efficient DNA repair – for poor people living in deve­lo­ping countries than 
	they are for affluent people living in North America or Western Europe?</span></font></p>
	<p class="MsoNormal" style="line-height: 12.0pt" align="justify">
	<font face="Verdana">
	<span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It may be mentioned that one of the enzymes needed by the 
	salvage pathway of thy­mi­dylate bio­syn­the­sis, <i>viz.</i> thymidine 
	kinase, is inhibited by the drug zidovudine (also called AZT). Zidovudine 
	was the first drug that was used at a large scale for treatment of HIV 
	disease.<a name="_ftnref141" title href="#_ftn141"><span class="MsoFootnoteReference">[141]</span></a> 
	It is still much used for treatment of AIDS, but now most commonly in 
	com­bi­na­tion with other anti-HIV drugs, which helps to inhibit viral 
	replication more ef­fec­tively than is possible with one drug alone and 
	therefore also helps to counteract (or delay) the evo­lu­tion of drug 
	resistance in the virus.<a name="_ftnref142" title href="#_ftn142"><span class="MsoFootnoteReference">[142]</span></a> 
	After entering the host cell, zidovudine is phos­pho­ry­lated by thymidine 
	kinase to zidovudine monophosphate, and finally by nucleoside di­phos­pha­te 
	kinase to active zido­vudine 5-triphosphate.<a name="_ftnref143" title href="#_ftn143"><span class="MsoFootnoteReference">[143]</span></a> 
	High concentrations of the mono­phos­pha­te may accumulate in the cell, and 
	the intracellular half-life of zidovudine 5-triphosphate is ap­pro­ximately 
	3 hours.<a name="_ftnref144" title href="#_ftn144"><span class="MsoFootnoteReference">[144]</span></a> 
	Zidovudine 5-triphosphate terminates viral DNA chain elon­ga­tion by 
	competing with thymidine tri­phos­pha­te for incorporation into viral DNA.<a name="_ftnref145" title href="#_ftn145"><span class="MsoFootnoteReference">[145]</span></a> 
	Zi­do­vu­di­ne 5-triphosphate also weakly in­hi­bits cellular DNA 
	polymerase-<i>alpha</i> and mitochondrial polymerase-<i>gamma</i>, and the 
	monophosphate com­pe­titively inhibits cel­lular thymidine ki­na­se, an 
	effect that reduces levels of thymidine triphosphate.<a name="_ftnref146" title href="#_ftn146"><span class="MsoFootnoteReference">[146]</span></a> 
	These latter effects may con­tri­bute to the drug’s cytotoxicity and adverse 
	effects.<a name="_ftnref147" title href="#_ftn147"><span class="MsoFootnoteReference">[147]</span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It may thus be 
	theoretically expected that the combination of folate de­fi­ci­ency and 
	zidovudine may by itself be enough to cause immunodeficiency, even when HIV 
	viral re­plication is ef­fi­ci­ently suppressed. This is because the 
	proliferation of leukocytes or their precursors will now be hindered by a 
	shor­ta­ge of thymidylate, which will lead to corres­pon­ding reduction of 
	the rate of DNA biosynthesis in the pro­li­fe­ra­ting cell popu­la­tion. 
	Since zidovudine is acting as a competitive inhibitor of the enzyme 
	concerned, it must be expected that this effect of zidovudine will be more 
	serious in a situation where the dietary intake of DNA is low, while a high 
	dietary intake of DNA possibly may help to overcome the sup­pression of 
	thymidylate biosynthesis caused by zidovudine at a therapeutic dosage level. 
	This might po­ten­tially be very important not only for the 
	pro­li­fe­ra­tion of leukocytes of va­ri­ous kinds (or their precursor 
	cells), but also for the proliferation of intestinal epi­the­­lial cells 
	(enterocytes and colonocytes).</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Suppression of 
	intes­tinal epithelial cell proliferation may cause development of villus 
	atrophy (“flat intestine”), which may in turn lead to malabsorbtion not only 
	of important nutrients (which may in turn en­han­ce the risk of diarrhoeas 
	caused not only by the reduction of the area of absorbtive surface, but also 
	by associated brush border oligosaccharidase de­fi­ciencies leading <i>e.g.</i> 
	to lactose intolerance or sucrose in­to­le­ran­ce), but presumably also <b>
	mal­absorbtion of drugs used either for treat­ment of the HIV disease itself 
	or for treat­ment of other infections, such as tu­ber­culosis or malaria.</b> 
	The effective dosage level of the drug con­cerned may thus become too low, 
	which will not only reduce the effect of the the­rapy, <b>but also must be 
	ex­pec­ted to increase the risk of drug resistance development in the 
	pathogenic organism con­cerned</b> - which might be the HIV virus itself, 
	but also <i>Myco­bac­terium tuberculosis</i> or some <i>Plasmodium</i> 
	spe­cies, <i>e.g.</i> <i>P. fal­ci­parum</i>,<i> </i>or any among several 
	other disease-causing organisms.<a name="_ftnref148" title href="#_ftn148"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[148]</span></span></a> 
	The putative public health con­se­quen­ces if this should occur at a mass 
	scale because of the liberation of cheap zidovudine for treatment of 
	millions of poor HIV patients in developing countries are indeed appalling - 
	and not only for the populations most di­rect­ly concerned; it will, for 
	instance, also make it much more dif­fi­cult for foreign medical personnel 
	or other aid workers to go to the countries con­cer­ned if there is no drug 
	available for treatment of malaria any more because the disease-cau­sing 
	organism as evol­ved mul­ti­re­sistance against absolutely all drugs 
	previously avail­able for treatment of this dangerous dis­ea­se. It may also 
	be ex­pec­ted that some of the multiresistant pathogens concerned (<i>e.g.</i> 
	mul­ti­re­sistant plasmodia) may spread rather easi­ly from one part of the 
	world to another (especially when patients who have been in­fec­ted with 
	some multi­re­sistant organism while travelling abroad finally return to 
	their ho­me­land). Not a very nice pros­pect for a futu­re ‘greenhouse 
	world’ - where insects res­pon­sible for the trans­mission of malaria and 
	other tropical dis­ea­ses may thrive also in several countries which are now 
	too cold for them!</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Finally, and 
	per­haps most se­rious­ly, <b>folate deficiency is mutagenic</b> <i>i.a.</i> 
	because of faulty in­cor­po­ration of uracil instead of thy­mi­ne into the 
	DNA molecule during DNA syn­thesis or repair.<a name="_ftnref149" title href="#_ftn149"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[149]</span></span></a> 
	This form of DNA damage can be repaired, but faulty repair is common, which 
	will lead to per­ma­nent mutations in the cells concerned, often in the form 
	of chro­mo­somal damage (following chromosome breaks).<a name="_ftnref150" title href="#_ftn150"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[150]</span></span></a> 
	During repair of uracil in DNA, transient nicks are for­med; two op­po­sing 
	nicks could lead to chromosome breaks.<a name="_ftnref151" title href="#_ftn151"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[151]</span></span></a> 
	A level of folate deficiency cau­sing chromosome breaks was found in 
	approximately 10% of the po­pu­lation in U.S.A., and in a much higher 
	percentage of the American poor.<a name="_ftnref152" title href="#_ftn152"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[152]</span></span></a></span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Again, it must 
	be expected that effect of a given degree of folate deficiency must depend 
	on the die­tary intake of DNA: folate deficiency must be expected to be more 
	strong­ly mutagenic when the dietary intake of DNA is low than when it is 
	high. It must also be expected that the mutagenic effect of folate 
	defi­ci­ency (be­cause of misincorporation of uracil in the DNA molecule 
	instead of thymine) must be enhanced by zi­do­vu­dine with the 
	com­bi­na­tion of zidovudine with low dietary intakes both of folate (and/or 
	vitamin B<sub>12</sub>) and DNA being especially dangerous. There may thus 
	be good reason to fear what may be the pos­sible consequences in terms of 
	DNA damage if zidovudine shall be used at a mass scale for treatment of 
	millions of HIV-infected patients (most of which are still in their fertile 
	age) in poor countries. The most important reason for concern is here not 
	what it could mean for the incidence of cancer or for biological aging 
	processes among the patients (because of more rapid accumulation of DNA 
	damage in the mitochondria), but what could be the pos­sible consequences 
	for future generations.&nbsp;&nbsp;&nbsp; </span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enhancement of 
	the rate of mutations in somatic cells will increase the risk of cancer when 
	it occurs in nuclear chromosomes<a name="_ftnref153" title href="#_ftn153"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[153]</span></span></a> 
	and en­han­ce the rate of biological aging when it occurs in mito­chondrial 
	DNA. A typical cell contains many mito­chondria, and each mito­chond­rion 
	con­tains many chromosomes, which may bring the total number of 
	mito­chondrial chro­mo­so­mes per cell to typically about 1000 (as against 
	only 2 per cell for each of the nuc­lear chro­mo­so­mes with exception of 
	the sex chromosomes in men). In a newborn child, there are there­fore 
	typically about 1000 copies of each mitochondrial gene per cell. But the 
	mutation rate is much higher for mitochondrial DNA than for nuclear DNA, 
	which means that more and more of the mitochondrial gene copies per cell 
	will be lost as an individual becomes older.<a name="_ftnref154" title href="#_ftn154"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[154]</span></span></a> 
	This will sooner or later lead to a situation where the synthesis rate for 
	critical mitochond­rial proteins will be decreased. This will first lead to 
	some degree of impairment of mito­chond­rial function (causing reduction of 
	the cellular capacity for ATP production and en­hanced oxidative stress), 
	but sooner or later (when the inhibition of mito­chondrial function becomes 
	more severe) to the death of the cells concerned. This may in turn lead to 
	organ failure which will in turn lead to the death of the orga­nism if some 
	very critical organ (<i>e.g.</i> the heart) is affected. No person can 
	survive his own mitochondria!</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There is strong 
	reason to believe that the process of&nbsp; progressive accumulation of DNA 
	lesions in the mitochondria (much of it in form of deletions) must be one of 
	the most fundamental mechanisms of aging, if not the most fundamental one, 
	in multicellular animal organisms.<a name="_ftnref155" title href="#_ftn155"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[155]</span></span></a> 
	It must be ex­pec­ted that the rate of mitochondrial DNA mutation can be 
	en­han­ced both as a result of factors that may enhance the rate of 
	production of primary mito­chondrial DNA lesions (before DNA repair has 
	taken place) and factors that may interfere with DNA repair. It may 
	therefore be expected that folate deficiency may be an important 
	contributory cause of accelerated mitochondrial aging.<a name="_ftnref156" title href="#_ftn156"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[156]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the rate of 
	mutation is enhanced also in the germ cells (<i>e.g.</i> in the 
	mitochondrial DNA of resting female germ cells), this will enhance the 
	burden of deleterious mutations in fu­tu­­re generations. Enhancement of the 
	mutagenic burden for future generations is also what should be considered by 
	far the most serious me­di­cal consequence of to­bac­­co smo­­king, worse 
	than the enhanced risk of dying from cancer or heart disease for the smoker 
	himself. But while girls at the age of puberty (when many of them will start 
	smoking) are warned against the risks of lung cancer and heart disease if 
	they start smoking, how many of them are warned that it can also damage 
	their egg cells – and that they should avoid intercourse with a boy who is a 
	tobacco smoker if they want to minimize the risk of getting genetically 
	unhealthy children, grandchildren or grandchildren’s grandchildren? And how 
	many of them are asked the question, what may be worst for themselves and 
	for society as a whole, either dying at a much too young age from an 
	overdose or heroin or morphine, making themselves a life-long psychiatric 
	casus through misuse of drugs (such as ecstacy) that kill 
	serotonin-producing and/or dopamine-producing nerve cells in their brain – 
	or misusing substances (such as tobacco and most probably also alcohol) that 
	may damage the DNA molecules of their children, grandchildren and 
	grand­child­ren’s grandchildren?</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enhancement of 
	the mutagenic burden for future generations must also be considered the most 
	se­ri­ous putative consequence of <b>inadequate control of direct or 
	indirect geno­­to­xi­ci­ty of substances used as drugs by mil­lions of 
	people.</b> This could be a potentially much underestimated problem because 
	the net now used in order to discover geno­to­xic sub­stances (including 
	drugs new and old) is not fine-mas­ked enough; <i>i.e.</i> <b>those tests 
	that are routinely used for mutagenicity scree­ning, such as the Ames test, 
	will not reveal all re­le­vant forms of direct or indirect 
	ge­no­­­­to­xi­city,</b> as in such cases where a substance which is inert 
	by itself (as far as genotoxicity is concerned) is metabolized by mammalian 
	cells into one or more substances that function as generators of reactive 
	oxy­gen species through a redox cyc­ling mechanism. And it is also much too 
	common that no ap­propriate re­gu­­la­to­ry action is ta­ken, even when 
	there is very good do­cu­mentation for the di­rect or indirect genotoxicity 
	and/or car­ci­no­ge­ni­city of sub­stances used as drugs (<i>e.g.</i> 
	zidovudine, also called AZT),<a name="_ftnref157" title href="#_ftn157"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[157]</span></span></a> 
	as food or feedstuff ad­di­ti­ves (<i>e.g.</i> BHT and BHA)<a name="_ftnref158" title href="#_ftn158"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[158]</span></span></a> 
	or for other such pur­po­ses that may lead to exposu­re of lar­ge num­bers 
	of peop­­le. It appears as if very short-sighted economic inte­rests too 
	often may have prio­ri­ty over the question of protection of our own genes. 
	What use (except for a short time of momentaneous pleasure) is there in the 
	transfer of DNA mole­cules from man to woman if the DNA molecules in the 
	germ cells both of the donor and recipient partner already are destroyed?</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana"><b>
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;</span></b><span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
	Another example of the same type of problem is the continued large-scale use 
	of dental amal­gam fillings for several years after the toxicological 
	hazards of mer­cu­ry (simi­larly as for various other toxic heavy metals) 
	had be­co­me over-abun­dantly docu­men­tated in the inter­na­tional 
	scien­ti­fic literature. Mercury can exert an im­por­tant indirect 
	ge­no­toxic effect because it may cause inhibition of H<sub>2</sub>O<sub>2</sub>-sca­ven­ging 
	selenium-de­pen­dent enzyme sys­tems vital for the protection of the DNA 
	mo­le­cules against H<sub>2</sub>O<sub>2</sub>-in­du­ced oxidative da­ma­ge. 
	H<sub>2</sub>O<sub>2</sub> damages DNA mole­cules.<a name="_ftnref159" title href="#_ftn159"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[159]</span></span></a> 
	This hap­pens mainly in reactions which are catalyzed by iron and other 
	redox-active metals.<a name="_ftnref160" title href="#_ftn160"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[160]</span></span></a> 
	The resulting damage is similar to that caused by ionizing radiation.<a name="_ftnref161" title href="#_ftn161"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[161]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mercury 
	inhibition of the thioredoxin re­duc­ta­se/thi­o­re­do­xin/2-Cys 
	per­oxi­redoxin sys­tem of H<sub>2</sub>O<sub>2</sub> sca­venging is 
	probably especially important here. 2-Cys per­oxi­re­do­xins scavenge H<sub>2</sub>O<sub>2</sub> 
	with reduced thio­re­do­xin as reducing cofactor.<a name="_ftnref162" title href="#_ftn162"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[162]</span></span></a> 
	This cofactor is next re­ge­nerated in its reduced form by thioredoxin 
	re­ductase, which is at the same time both a fla­voprotein, a dithiol-enzyme 
	and a seleno­pro­tein using NADPH as its reducing cofactor.<a name="_ftnref163" title href="#_ftn163"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[163]</span></span></a> 
	Thio­re­do­xin re­duc­tase has a very unusual structure with 
	sele­no­cys­teyl and cysteyl groups in neighbour po­si­tion, making this 
	enzyme un­usua­lly sen­sitive to in­hi­bi­tion by toxic heavy metals.<a name="_ftnref164" title href="#_ftn164"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[164]</span></span></a> 
	As an ex­ample, it may be men­tio­ned that the sen­si­ti­vity of this enzyme 
	to the organic gold compound auranofin (which is used for treatment of 
	rheu­­matoid arth­ritis) is more than 1000-fold higher than the 
	sen­si­ti­vi­ties of glu­ta­thio­ne per­oxi­dase (which is an­other 
	sele­no­pro­tein) and of the dithiol en­zy­me glu­ta­thio­ne re­duc­ta­se to 
	auranofin.<a name="_ftnref165" title href="#_ftn165"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[165]</span></span></a>
	</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This indirect 
	genotoxic effect of mercury (be­cau­se it inhibits se­le­ni­um-de­pen­dent 
	enzyme systems important for protection of the DNA molecules against H<sub>2</sub>O<sub>2</sub>-induced 
	damage) must be expected to dependent on the level of selenium intake, so 
	that it may be en­han­ced when the selenium intake is low and reduced when 
	the selenium intake is high. However, the ave­ra­ge se­le­nium intake is 
	dan­ge­rous­ly low in several European countries including the United 
	Kingdom,<a name="_ftnref166" title href="#_ftn166"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[166]</span></span></a> 
	while no re­gu­la­tory action is by the health authorities in the countries 
	concerned (including Norway, Den­mark and Sweden) in order to correct this 
	problem – with the only ex­cep­tion of Finland among European countries.</span></font></p>
	<p class="MsoFootnoteText" align="justify"><font face="Verdana">
	<span lang="EN-GB" style="font-family: CG Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There seems 
	also to be very little interest among the regulatory agencies and 
	inter­national or­ga­ni­za­tions con­cerned about the mu­ta­ge­nic effects 
	of dietary deficiency con­di­tions (such as suboptimal intakes – which may 
	or may not lead to cli­ni­cal defi­ci­en­cy symptoms – of folate, vitamin B<sub>12</sub>, 
	selenium or sulfur ami­no acids) and the con­se­quen­ces such diet-in­du­ced 
	mutations may have for the health of future generations. <b>Man is not only 
	the cause of widespread de­fo­res­ta­tion causing acce­lerated soil erosion 
	all over the world;</b><a name="_ftnref167" title href="#_ftn167"><span class="MsoFootnoteReference"><span lang="EN-GB" style="font-size: 12.0pt; font-family: CG Times">[167]</span></span></a>
	<b>we are also damaging our genes and ero­ding our own genetic heritage in a 
	way and at a tempo which po­ten­tially might threaten our future survival as 
	a spe­cies</b>.</span></font></p>
	<blockquote>
		<div style="mso-element:footnote-list">
			<br clear="all">
&nbsp;<hr align="left" size="1" width="33%">
			<div style="mso-element:footnote" id="ftn1">
				<p class="MsoFootnoteText">
				<a name="_ftn1" title href="#_ftnref1">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[1]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Björn, L.O. and T. Wang: Vitamin D in an ecological context. <u>
				Int</u>. <u>J</u>. <u>Circum­polar Health</u>, 2000, <u>59</u>, 
				26-32; Nor­man, A.W.: Sunlight, season, skin pigmentation, 
				vitamin D, and 25-hyd­ro­xy­vitamin D: integral components of 
				the vitamin D endocrine system. <u>Am</u>. <u>J</u>. <u>Clin</u>.
				<u>Nutr</u>., 1998, <u>67</u>, 1108-1110; Holick, M.G.: The 
				cutaneous pho­to­synthesis of previtamin D<sub>3</sub>: a unique 
				photoendocrine system. <u>J</u>. <u>Invest</u>. <u>Der­matol</u>., 
				1981, <u>77</u>, 51-58.</span></div>
			<div style="mso-element:footnote" id="ftn2">
				<p class="MsoFootnoteText">
				<a name="_ftn2" title href="#_ftnref2">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[2]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Frederick, J.E., V.W. Manner and C.R. Booth: Interannual 
				va­ria­bility in solar ultraviolet irradiance over decadal 
				scales at latitude 55 degrees south. <u>Photochem</u>. <u>
				Pho­to­biol</u>., 2001, <u>74</u>, 771-779; Bras­seur, G.P., J.J. 
				Orlando and G.S. Tyn­dall (Eds.): <b><i>Atmospheric Che­mist­ry 
				and Glo­bal Chan­ge.</i></b> Oxford Uni­ver­si­ty Press, New 
				York and Oxford 1999.</span></div>
			<div style="mso-element:footnote" id="ftn3">
				<p class="MsoFootnoteText">
				<a name="_ftn3" title href="#_ftnref3">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[3]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Orlando and Tyn­dall (eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn4">
				<p class="MsoFootnoteText">
				<a name="_ftn4" title href="#_ftnref4">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[4]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Abarca, J.F. and C.C. Casiccia: Skin cancer and ultra­vio­let-B 
				radiation under the Antarctic ozone hole: sou­thern Chile, 
				1987-2000. <u>Photodermatol</u>. <u>Photo­im­mu­nol</u>. <u>
				Pho­to­med</u>., 2002, <u>18</u>, 294-302; Meador, J. <u>et al</u>.: 
				Sea­so­nal fluctuation of DNA photodamage in ma­ri­ne plankton 
				assemblages at Palmer Station, Antarctica. <u>Pho­­­tochem</u>.
				<u>Photobiol</u>., 2002, <u>75</u>, 266-271; Brasseur, Orlando 
				and Tyndall (eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn5">
				<p class="MsoFootnoteText">
				<a name="_ftn5" title href="#_ftnref5">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[5]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				For discussion of the importance of clo­thing for the synthesis 
				of vitamin D in the skin, see: Matsuoka, L.Y. <u>et al</u>.: 
				Clothing prevents ultraviolet-B radiation-dependent 
				pho­to­synthesis of vi­ta­min D<sub>3</sub>. <u>J</u>. <u>Clin</u>.
				<u>Endocrinol</u>. <u>Me­tab</u>., 1992, <u>75</u>, 1099-1103.
				</span></div>
			<div style="mso-element:footnote" id="ftn6">
				<p class="MsoFootnoteText">
				<a name="_ftn6" title href="#_ftnref6">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[6]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Andersen, B.G. and H.W. Borns, Jr.: <b><i>The Ice Age World.</i></b> 
				Scandinavian University Press, Oslo 1994.</span></div>
			<div style="mso-element:footnote" id="ftn7">
				<p class="MsoFootnoteText">
				<a name="_ftn7" title href="#_ftnref7">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[7]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Andersen and Borns, 1994, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn8">
				<p class="MsoFootnoteText">
				<a name="_ftn8" title href="#_ftnref8">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[8]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Leakey, R.E.: <b><i>The Making of Mankind.</i></b> Michael 
				Joseph, London 1981.</span></div>
			<div style="mso-element:footnote" id="ftn9">
				<p class="MsoFootnoteText">
				<a name="_ftn9" title href="#_ftnref9">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[9]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Leakey, 1981, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn10">
				<p class="MsoFootnoteText">
				<a name="_ftn10" title href="#_ftnref10">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[10]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Con­stanze, E. <u>et al</u>.: Cool glacial temperatures and 
				changes in moisture source recorded in Oman ground­waters. <u>
				Science</u>, 2000, <u>287</u>, 842-845.</span></div>
			<div style="mso-element:footnote" id="ftn11">
				<p class="MsoFootnoteText">
				<a name="_ftn11" title href="#_ftnref11">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[11]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Monnin, E. <u>et al</u>.: At­mo­sphe­­ric CO<sub>2</sub> 
				concentrations over the last glacial termina­tion. <u>Science</u>, 
				2001, <u>291</u>, 112-114; Sigman, D.M. and E.A. Boyle: 
				Glacial/interglacial variations in at­mo­spheric carbon dioxide.
				<u>Nature</u>, 2000, <u>407</u>, 859-869; Stephens, B.B. and 
				R.F. Keeling: The influence of Ant­arc­tic sea ice on 
				glacial-interglacial CO<sub>2</sub> variations. <u>Nature</u>, 
				2000, <u>404</u>, 171-174; Smith, H.J. <u>et al</u>.: Dual modes 
				of the carbon cycle since the Last Glacial Ma­xi­mum. <u>Natu­re</u>, 
				1999, <u>400</u>, 248-250; Andersen and Borns, 1994, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn12">
				<p class="MsoFootnoteText">
				<a name="_ftn12" title href="#_ftnref12">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[12]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Stephens and Keeling, 2000, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn13">
				<p class="MsoFootnoteText">
				<a name="_ftn13" title href="#_ftnref13">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[13]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				El­der­field, H. and R.E. Rickaby: Oceanic Cd/P ratio and 
				nutrient utilization in the glacial Southern Ocean. <u>Nature</u>, 
				2000, <u>405</u>, 305-310; Stephens and Keeling, 2000, <i>op. 
				cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn14">
				<p class="MsoFootnoteText">
				<a name="_ftn14" title href="#_ftnref14">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[14]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Watson, A.J. <u>et al</u>.: Effect of iron supply on Sou­thern 
				Ocean CO<sub>2</sub> uptake and im­pli­ca­tions for glacial 
				atmo­sphe­ric CO<sub>2</sub>. <u>Nature</u>, 2000, <u>407</u>, 
				730-733.</span></div>
			<div style="mso-element:footnote" id="ftn15">
				<p class="MsoFootnoteText">
				<a name="_ftn15" title href="#_ftnref15">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[15]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Watson et al., 2000, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn16">
				<p class="MsoFootnoteText">
				<a name="_ftn16" title href="#_ftnref16">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[16]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Watson et al., 2000, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn17">
				<p class="MsoFootnoteText">
				<a name="_ftn17" title href="#_ftnref17">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[17]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Severinghaus, J.P. and E.J. Brook: Abrupt climate change at the 
				end of the last glacial period inferred from trapped air in 
				polar ice. <u>Science</u>, 1999, <u>286</u>, 930-934.</span></div>
			<div style="mso-element:footnote" id="ftn18">
				<p class="MsoFootnoteText">
				<a name="_ftn18" title href="#_ftnref18">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[18]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Fluckiger, J. <u>et al</u>.: Variations in atmospheric N<sub>2</sub>O 
				concentration during abrupt climatic changes, <u>Sci­ence</u>, 
				1999, <u>285</u>, 227-230.</span></div>
			<div style="mso-element:footnote" id="ftn19">
				<p class="MsoFootnoteText">
				<a name="_ftn19" title href="#_ftnref19">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[19]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Nisbet, E.G.: Have sudden large releases of methane from 
				geological re­ser­voirs occurred since the Last Glacial Maximum, 
				and could such re­lea­ses occur again? <u>Phi­los</u>. <u>Trans</u>.
				<u>Ser</u>. <u>A Math</u>. <u>Phys</u>. <u>Eng</u>. <u>Sci</u>., 
				2002, <u>360</u>, 581-607; Bras­seur, G.P., J.J. Orlando and 
				G.S. Tyn­dall (Eds.): <b><i>Atmospheric Che­mist­ry and Glo­bal 
				Chan­ge.</i></b> Oxford Uni­ver­si­ty Press, New York and Oxford 
				1999; Fluckiger <u>et al</u>., 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn20">
				<p class="MsoFootnoteText">
				<a name="_ftn20" title href="#_ftnref20">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[20]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Orlando and Tyn­dall (Eds.), 1999, <i>op. cit.</i>; 
				Butcher, S.S., R.J. Charlson, G.H. Orians and G.V. Wolfe (Eds.):
				<b><i>Global Biogeo­che­mical Cycles.</i></b> Academic Press, 
				New York 1992; McElroy, M.B., S.C. Wofsky and Y.L. Young: The 
				nitrogen cycle: Perturbations due to man and their impact on 
				atmospheric N<sub>2</sub>O and O<sub>3</sub>. <u>Phil</u>. <u>
				Trans</u>. <u>Roy</u>. <u>Soc</u>. <u>Lond</u>., 1977, <u>B277</u>, 
				159-181; McElroy, M.B. <u>et al</u>: Sources and sinks for 
				atmo­sphe­ric N<sub>2</sub>O. <u>Rev</u>. <u>Geo</u>. <u>Space 
				Phys</u>., 1976, <u>14</u>, 143-150.</span></div>
			<div style="mso-element:footnote" id="ftn21">
				<p class="MsoFootnoteText">
				<a name="_ftn21" title href="#_ftnref21">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[21]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Orlando and Tyn­dall (Eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn22">
				<p class="MsoFootnoteText">
				<a name="_ftn22" title href="#_ftnref22">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[22]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Orlando and Tyn­dall (Eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn23">
				<p class="MsoFootnoteText">
				<a name="_ftn23" title href="#_ftnref23">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[23]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Orlando and Tyn­dall (Eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn24">
				<p class="MsoFootnoteText">
				<a name="_ftn24" title href="#_ftnref24">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[24]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Orlando and Tyn­dall (Eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn25">
				<p class="MsoFootnoteText">
				<a name="_ftn25" title href="#_ftnref25">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[25]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Orlando and Tyn­dall (Eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn26">
				<p class="MsoFootnoteText">
				<a name="_ftn26" title href="#_ftnref26">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[26]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Orlando and Tyn­dall (Eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn27">
				<p class="MsoFootnoteText">
				<a name="_ftn27" title href="#_ftnref27">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[27]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span style="font-size: 10.0pt; font-family: Times New Roman">
				Petit-Mai­re, N. <u>et</u> <u>al</u>.: Geo­lo­gi­cal records of 
				the recent past, a key to the near future world envi­ron­ments.
				<u>Epi­so­des</u>, 2000, <u>23</u>, 230-246</span><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">;
				</span>
				<span style="font-size: 10.0pt; font-family: Times New Roman">
				Sarnthein, M.: Sand deserts during glacial ma­xi­mum and 
				minimum. <u>Natu</u>­<u>re</u>, 1978, <u>22</u>, 43-46.</span><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">&nbsp;
				</span></div>
			<div style="mso-element:footnote" id="ftn28">
				<p class="MsoFootnoteText">
				<a name="_ftn28" title href="#_ftnref28">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[28]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Or­lan­do and Tyn­dall (Eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn29">
				<p class="MsoFootnoteText">
				<a name="_ftn29" title href="#_ftnref29">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[29]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Chester, R.: <b><i>Marine Geochemistry. </i></b>Unwin Hyman, 
				London 1990.</span></div>
			<div style="mso-element:footnote" id="ftn30">
				<p class="MsoFootnoteText">
				<a name="_ftn30" title href="#_ftnref30">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[30]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Or­lan­do and Tyn­dall (Eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn31">
				<p class="MsoFootnoteText">
				<a name="_ftn31" title href="#_ftnref31">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[31]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See: Clark, P.U. <u>et al</u>.: The role of the thermohaline 
				circulation in abrupt climate change. <u>Natu­re</u>, 2002, <u>
				415</u>, 863-869.&nbsp; </span></div>
			<div style="mso-element:footnote" id="ftn32">
				<p class="MsoFootnoteText">
				<a name="_ftn32" title href="#_ftnref32">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[32]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See Chester, 1990, <i>op. cit.</i> for information about the 
				biological pro­duction of some of these gases in the sea.</span></p>
				<p class="MsoFootnoteText"><span lang="NO-BOK">&nbsp;</span></div>
			<div style="mso-element:footnote" id="ftn33">
				<p class="MsoFootnoteText">
				<a name="_ftn33" title href="#_ftnref33">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[33]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Bras­seur, Orlando and Tyn­dall (Eds.), 1999, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn34">
				<p class="MsoFootnoteText">
				<a name="_ftn34" title href="#_ftnref34">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[34]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Oeschger, H.: CO<sub>2</sub> and the greenhouse effect: pre­sent 
				assessment and perspectives. <u>Ciba Found</u>. <u>Symp</u>., 
				1993, <u>175</u>, 2-17; discussion 17-22; Andersen and Born, 
				1994, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn35">
				<p class="MsoFootnoteText">
				<a name="_ftn35" title href="#_ftnref35">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[35]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Con­stanze, E. <u>et al</u>.: Cool glacial temperatures and 
				changes in mois­tu­re source recorded in Oman ground­waters. <u>
				Science</u>, 2000, <u>287</u>, 842-845.</span></div>
			<div style="mso-element:footnote" id="ftn36">
				<p class="MsoFootnoteText">
				<a name="_ftn36" title href="#_ftnref36">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[36]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Constanze <u>et al</u>., 2000, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn37">
				<p class="MsoFootnoteText">
				<a name="_ftn37" title href="#_ftnref37">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[37]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Constanze <u>et al</u>., 2000, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn38">
				<p class="MsoFootnoteText">
				<a name="_ftn38" title href="#_ftnref38">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[38]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Constanze <u>et al</u>., 2000, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn39">
				<p class="MsoFootnoteText">
				<a name="_ftn39" title href="#_ftnref39">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[39]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Constanze <u>et al</u>., 2000, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn40">
				<p class="MsoFootnoteText">
				<a name="_ftn40" title href="#_ftnref40">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[40]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Andersen, B.G. and H.W. Borns, Jr.: <b><i>The Ice Age World.</i></b> 
				Scandinavian University Press, Oslo 1994, Second edition 1997.</span></div>
			<div style="mso-element:footnote" id="ftn41">
				<p class="MsoFootnoteText">
				<a name="_ftn41" title href="#_ftnref41">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[41]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Faure, G.: <b><i>Principles of Isotope Geology</i></b>. Se­cond 
				Edition. Cambridge University Press, Cambridge 1986.</span></div>
			<div style="mso-element:footnote" id="ftn42">
				<p class="MsoFootnoteText">
				<a name="_ftn42" title href="#_ftnref42">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[42]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Dahl-Jensen, D. <u>et al</u>.: Past temperatures directly from 
				the Greenland Ice Sheet. <u>Science</u>, 1998, <u>282</u>, 
				268-271.</span></div>
			<div style="mso-element:footnote" id="ftn43">
				<p class="MsoFootnoteText">
				<a name="_ftn43" title href="#_ftnref43">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[43]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See: Andersen, B.G. and H.W. Borns, Jr.: <b><i>The Ice Age 
				World.</i></b> Scandinavian University Press, Oslo 1994, Second 
				edition 1997.</span></div>
			<div style="mso-element:footnote" id="ftn44">
				<p class="MsoFootnoteText">
				<a name="_ftn44" title href="#_ftnref44">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[44]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Karafet, T.M. <u>et al</u>.: High levels of Y-chromosome 
				differentiation among native Si­be­rian populations and the 
				genetic signature of a boreal hun­ter-gatherer way of life. <u>
				Hum</u>. <u>Biol</u>., 2002, <u>74</u>, 761-789.</span></div>
			<div style="mso-element:footnote" id="ftn45">
				<p class="MsoFootnoteText">
				<a name="_ftn45" title href="#_ftnref45">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[45]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Ham­mer, M.F. <u>et al</u>.: Hierarchical patterns of global 
				human Y-chromosome diversity. <u>Mol</u>. <u>Biol</u>. <u>Evol</u>., 
				2001, <u>18</u>, 1189-1203.&nbsp; </span></div>
			<div style="mso-element:footnote" id="ftn46">
				<p class="MsoFootnoteText">
				<a name="_ftn46" title href="#_ftnref46">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[46]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Wells, R.S. <u>et al</u>.: The Eurasian heartland: a continental 
				perspective on Y-chromosome diversity. <u>Proc</u>. <u>Natl</u>.
				<u>Acad</u>. <u>Sci</u>. <u>USA</u>, 2001, <u>98</u>, 
				10244-10249.</span></div>
			<div style="mso-element:footnote" id="ftn47">
				<p class="MsoFootnoteText">
				<a name="_ftn47" title href="#_ftnref47">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[47]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Kachondam, Y. <u>et al</u>.: Child health and nut­ri­tional 
				status in Ulaan­baa­tar, Mongolia: a preliminary assessment. <u>
				Asia Pac</u>. <u>J</u>. <u>Public Health</u>, 1992-93, <u>6</u>, 
				226-232.</span></div>
			<div style="mso-element:footnote" id="ftn48">
				<p class="MsoFootnoteText">
				<a name="_ftn48" title href="#_ftnref48">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[48]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See: Børresen, B.: <b><i>Den ensomme apen.</i></b> <i>Instinkt 
				på avveie.</i> [The lonely ape. Misdirected instinct] [Book in 
				Norwegian]. </span>
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				Gyldendal Norsk Forlag, Oslo 1996.</span></div>
			<div style="mso-element:footnote" id="ftn49">
				<p class="MsoFootnoteText">
				<a name="_ftn49" title href="#_ftnref49">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[49]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See Børresen, 1996, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn50">
				<p class="MsoFootnoteText">
				<a name="_ftn50" title href="#_ftnref50">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[50]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Braunwald, E. <u>et al</u>. </span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				(Eds.): <b><i>Harrison’s Principles of Internal Medicine.</i></b> 
				15<sup>th</sup> Edition. McGraw-Hill, New York 2001.</span></div>
			<div style="mso-element:footnote" id="ftn51">
				<p class="MsoFootnoteText">
				<a name="_ftn51" title href="#_ftnref51">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[51]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Braunwald <u>et al</u>. (Eds.), 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn52">
				<p class="MsoFootnoteText">
				<a name="_ftn52" title href="#_ftnref52">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[52]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Braunwald <u>et al</u>. (Eds.), 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn53">
				<p class="MsoFootnoteText">
				<a name="_ftn53" title href="#_ftnref53">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[53]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian, A. <u>et al</u>.: Improved mineral balance and 
				skeletal metabolism in postmenopausal women treated with 
				potassium bi­car­bonate. <u>N</u>. <u>Engl</u>. <u>J</u>. <u>Med</u>., 
				1994, <u>330</u>, 1776-1781; Lemann, J., Jr., J.A. Pleuss and 
				R.W. Gray: Po­tas­sium causes calcium retention in healthy 
				adults. <u>J</u>. <u>Nutr</u>., 1993, <u>123</u>, 1623-1626; 
				Einhorn, T.A.: Dietary pro­tein and bone calcium metabolism. In: 
				Simmons, D.J. (Ed.): <b><i>Nutrition and Bone Development.</i></b> 
				Oxford Uni­ver­sity Press, New York and Oxford 1990, pp. 
				223-236; Lemann, J., Jr., R.W. Gray and J.A. Pleuss: Po­tas­sium 
				bi­car­bo­nate, but not sodium bicarbonate, reduces urinary 
				calcium excretion and improves calcium balance in heal­thy men.
				<u>J</u>. <u>Kidney Int</u>., 1989, <u>35</u>, 688-695.</span></div>
			<div style="mso-element:footnote" id="ftn54">
				<p class="MsoFootnoteText">
				<a name="_ftn54" title href="#_ftnref54">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[54]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Maurer, M. <u>et al</u>.: Neut­ra­li­zation of Wes­tern diet 
				inhibits bone resorbtion independently of K intake and re­du­ces 
				cor­ti­sol secretion in humans. <u>Am</u>. <u>J</u>. <u>Physiol</u>.
				<u>Renal Phy­si­ol</u>., 2003, <u>284</u>, F32-F40.</span></div>
			<div style="mso-element:footnote" id="ftn55">
				<p class="MsoFootnoteText">
				<a name="_ftn55" title href="#_ftnref55">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[55]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Maurer <u>et al</u>., 2003, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn56">
				<p class="MsoFootnoteText">
				<a name="_ftn56" title href="#_ftnref56">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[56]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Gorman Hills, A.: <b><i>Acid-Base Balance. Chemistry, 
				Phy­sio­lo­gy, Pa­tho­physiology.</i></b> The Williams &amp; Wilkins 
				Company, Baltimore 1973.</span></div>
			<div style="mso-element:footnote" id="ftn57">
				<p class="MsoFootnoteText">
				<a name="_ftn57" title href="#_ftnref57">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[57]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Gorman Hills, 1973, <i>op. cit</i>.</span></div>
			<div style="mso-element:footnote" id="ftn58">
				<p class="MsoFootnoteText">
				<a name="_ftn58" title href="#_ftnref58">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[58]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Gorman Hills, 1973, <i>op. cit</i>.</span></div>
			<div style="mso-element:footnote" id="ftn59">
				<p class="MsoFootnoteText">
				<a name="_ftn59" title href="#_ftnref59">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[59]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Gorman Hills, 1973, <i>op. cit</i>.</span></div>
			<div style="mso-element:footnote" id="ftn60">
				<p class="MsoFootnoteText">
				<a name="_ftn60" title href="#_ftnref60">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[60]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Koi­vistoinen, P. (Ed.): <b><i>Mineral Element Composition of 
				Finnish Foods: N, K, Ca, Mg, P, S, Fe, Cu, Mn, Zn, Mo, Co, Ni, 
				Cr, F, Se, Si, Rb, Al, B, Br, Hg, A, C, Pb, and Ash.</i></b> <u>
				Acta Agriculturae Scan­dinavica</u>, <u>Sup­ple­mentum 22</u>. 
				Stockholm, Sweden 1980.</span></div>
			<div style="mso-element:footnote" id="ftn61">
				<p class="MsoFootnoteText">
				<a name="_ftn61" title href="#_ftnref61">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[61]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">Gorman 
				Hills, 1973, <i>op. cit</i>.</span></div>
			<div style="mso-element:footnote" id="ftn62">
				<p class="MsoFootnoteText">
				<a name="_ftn62" title href="#_ftnref62">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[62]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian, A. <u>et al</u>.: Estimation of the net acid load of 
				the diet of ancestral preagricultural <i>Homo sapiens</i> and 
				their hominid ancestors. <u>Am</u>. <u>J</u>. <u>Clin</u>. <u>
				Nutr</u>., 2002, <u>76</u>, 1308-1316.&nbsp; </span></div>
			<div style="mso-element:footnote" id="ftn63">
				<p class="MsoFootnoteText">
				<a name="_ftn63" title href="#_ftnref63">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[63]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian <u>et al</u>., 2002, <i>op. cit.</i> </span></div>
			<div style="mso-element:footnote" id="ftn64">
				<p class="MsoFootnoteText">
				<a name="_ftn64" title href="#_ftnref64">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[64]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian <u>et al</u>., 2002, <i>op. cit.</i> </span></div>
			<div style="mso-element:footnote" id="ftn65">
				<p class="MsoFootnoteText">
				<a name="_ftn65" title href="#_ftnref65">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[65]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian <u>et al</u>., 2002, <i>op. cit.</i> </span></div>
			<div style="mso-element:footnote" id="ftn66">
				<p class="MsoFootnoteText">
				<a name="_ftn66" title href="#_ftnref66">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[66]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian, A. <u>et al</u>.: Im­pro­ved mineral balance and 
				skeletal metabolism in postmenopausal women treated with 
				potassium bicarbonate. </span><u>
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				N</span></u><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">.
				<u>Engl</u>. <u>J</u>. <u>Med</u>., 1994, <u>330</u>, 1776-1781.</span></div>
			<div style="mso-element:footnote" id="ftn67">
				<p class="MsoFootnoteText">
				<a name="_ftn67" title href="#_ftnref67">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[67]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian <u>et al</u>., 1994, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn68">
				<p class="MsoFootnoteText">
				<a name="_ftn68" title href="#_ftnref68">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[68]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian <u>et al</u>., 1994, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn69">
				<p class="MsoFootnoteText">
				<a name="_ftn69" title href="#_ftnref69">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[69]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebas­tian <u>et al</u>., 2002, <i>op. cit.</i>; Frasetto.
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				L. <u>et al</u>.: Diet, evolution and aging – the 
				pathophysiologic effects of the post-ag­ri­cul­tural inversion 
				of the potassium-to-sodium and base-to-chloride ratios in the 
				human diet. </span><u>
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				Eur</span></u><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">.
				<u>J</u>. <u>Nutr</u>., 2001, <u>40</u>, 200-213. </span></div>
			<div style="mso-element:footnote" id="ftn70">
				<p class="MsoFootnoteText">
				<a name="_ftn70" title href="#_ftnref70">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[70]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian <u>et al</u>., 2002, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn71">
				<p class="MsoFootnoteText">
				<a name="_ftn71" title href="#_ftnref71">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[71]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian <u>et al</u>., 2002, <i>op. cit.</i>; Frasetto <u>et 
				al</u>., 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn72">
				<p class="MsoFootnoteText">
				<a name="_ftn72" title href="#_ftnref72">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[72]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Savidge, J. <u>et al</u>.: Cloning and functional 
				characterization of the guinea pig vanilloid receptor 1. <u>
				Neuro­phar­ma­co­logy</u>, 2002, <u>43</u>, 450-456; Tominaga, 
				M. <u>et al</u>.: The cloned capsaicin receptor integrates 
				multiple pain-pro­du­cing stimuli. <u>Neuron</u>, 1998, <u>21</u>, 
				531-543.</span></div>
			<div style="mso-element:footnote" id="ftn73">
				<p class="MsoFootnoteText">
				<a name="_ftn73" title href="#_ftnref73">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[73]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Savidge <u>et al</u>., 2002, <i>op. cit.</i>; Tominaga <u>et al</u>., 
				1998, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn74">
				<p class="MsoFootnoteText">
				<a name="_ftn74" title href="#_ftnref74">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[74]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				McVey, D.C. <u>et al</u>.: Endocannabinoids induce ileitis in 
				rats via the capsaicin receptor</span><span lang="EN-GB" style="font-family: CG Times">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: CG Times">
				(VR1). <u>J</u>. <u>Pharmacol</u>. <u>Exp</u>. <u>Ther</u>., 
				2003, <u>304</u>, 13-22.</span></div>
			<div style="mso-element:footnote" id="ftn75">
				<p class="MsoFootnoteText">
				<a name="_ftn75" title href="#_ftnref75">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[75]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Hwang, S.W. <u>et al</u>.: Direct activation of capsaicin 
				receptors by products of lipoxygenases: endogenous 
				cap­sai­cin-like substances. <u>Proc</u>. <u>Natl</u>. <u>Acad</u>.
				<u>Sci</u>. <u>USA</u>, 2000, <u>97</u>, 6155-6160.</span></div>
			<div style="mso-element:footnote" id="ftn76">
				<p class="MsoFootnoteText">
				<a name="_ftn76" title href="#_ftnref76">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[76]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Hwang <u>et al</u>., 2000, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn77">
				<p class="MsoFootnoteText">
				<a name="_ftn77" title href="#_ftnref77">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[77]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Tominaga <u>et al</u>., 1998, <i>op. cit.</i>; Savidge <u>et al</u>., 
				2002, <i>op. cit.</i> </span></div>
			<div style="mso-element:footnote" id="ftn78">
				<p class="MsoFootnoteText">
				<a name="_ftn78" title href="#_ftnref78">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[78]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				To­mi­naga <u>et al</u>., 1998, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn79">
				<p class="MsoFootnoteText">
				<a name="_ftn79" title href="#_ftnref79">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[79]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Frasetto <u>et al</u>., 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn80">
				<p class="MsoFootnoteText">
				<a name="_ftn80" title href="#_ftnref80">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[80]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				See: Liu, J. <u>et al</u>.: De­lay­ing brain mitochondrial decay 
				and aging with mitochondrial antioxidants and meta­bo­li­tes. <u>
				Ann</u>. <u>N</u>. <u>Y</u>. <u>Acad</u>. <u>Sci</u>., 2002, <u>
				959</u>, 133-166; Wallace, D.C.: Mi­to­chondrial DNA in aging 
				and disease. <u>Sci­en­tific American</u>, 1997 August, <u>277</u> 
				(2), 40-47.</span></div>
			<div style="mso-element:footnote" id="ftn81">
				<p class="MsoFootnoteText">
				<a name="_ftn81" title href="#_ftnref81">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[81]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sand­qvist, N.M., J.W. Eriks­son and P.A.Jansson: Increased 
				lactate release per fat cell in nor­mo­glycemic first-degree 
				relatives of individuals with type 2 diabetes. <u>Diabetes</u>, 
				2001, <u>50</u>, 2344-2348; van der Mer­we, M.T. <u>et al</u>.: 
				Lactate and glycerol release from adipose tissue in lean, obese 
				and diabetic women from South Africa. <u>J</u>. <u>Clin</u>. <u>
				Endocrinol</u>. <u>Metab</u>., 2001, <u>86</u>, 3296-3303. &nbsp;</span></div>
			<div style="mso-element:footnote" id="ftn82">
				<p class="MsoFootnoteText">
				<a name="_ftn82" title href="#_ftnref82">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[82]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Kelly, W.N.: Effects of drugs on uric acid in man. <u>Annu</u>.
				<u>Rev</u>. <u>Pharmacol</u>., 1975, <u>15</u>, 327-350.</span></div>
			<div style="mso-element:footnote" id="ftn83">
				<p class="MsoFootnoteText">
				<a name="_ftn83" title href="#_ftnref83">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[83]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Kel­ly, 1975, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn84">
				<p class="MsoFootnoteText">
				<a name="_ftn84" title href="#_ftnref84">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[84]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See: Roch-Ramel, F., D. Werner and B. Gui­­san: Urate trans­port 
				in brush-border membrane of human kidney. <u>Am</u>. <u>J</u>.
				<u>Physio</u>l., 1994, 266, F797-F805; Yamamoto, T. <u>et al</u>.: 
				Ef­fect of DL-sodium lactate in­fu­sion on excretion of purine 
				bases and oxy­purinol. <u>Int</u>. <u>J</u>. <u>Clin</u>. <u>
				Pharmacol</u>. <u>Ther</u>. <u>To­xicol</u>., 1993, <u>31</u>, 
				588-592; Yamamoto, T. <u>et al</u>.: Effect of lactate infusion 
				on renal transport of pu­ri­ne bases and oxy­purinol. <u>Nephron</u>, 
				1993, <u>65</u>, 73-76; Guggino, S.E., G.J. Martin and P.S. 
				Aron­son: Spe­cificity and modes of the anion exchange in dog 
				renal microvillus mem­branes. <u>Am</u>. <u>J</u>. <u>Physiol</u>., 
				1983, <u>244</u>, F612-F621; Kelly, 1975, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn85">
				<p class="MsoFootnoteText">
				<a name="_ftn85" title href="#_ftnref85">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[85]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian <u>et al</u>., 2002, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn86">
				<p class="MsoFootnoteText">
				<a name="_ftn86" title href="#_ftnref86">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[86]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Lemann, J., Jr., R.W. Gray and J.A. Pleuss: Potassium 
				bi­car­bo­nate, but not sodium bicarbonate, reduces uri­nary 
				calcium excretion and improves calcium ba­lan­ce in healthy men.
				<u>J</u>. <u>Kid­ney Int</u>., 1989, <u>35</u>, 688-695.</span></div>
			<div style="mso-element:footnote" id="ftn87">
				<p class="MsoFootnoteText">
				<a name="_ftn87" title href="#_ftnref87">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[87]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Tsuritani, I. <u>et al</u>.: Im­pair­­ment of vitamin D 
				metabolism due to environmental cadmium exposure, and pos­sib­le 
				re­le­van­ce to sex-related dif­fe­ren­ces in vulnerability to 
				the bone damage. <u>J</u>. <u>Toxicol</u>. <u>En­viron</u>. <u>
				Health</u>, 1992, <u>37</u>, 519-533; Szabo, A. <u>et al</u>.: 
				Hyperparathyroidism and abnormal 1,25(OH)<sub>2 </sub>vitamin D<sub>3</sub> 
				meta­bo­lism in expe­ri­men­tal lead intoxication. <u>Eur</u>.
				<u>J</u>. <u>Clin</u>. <u>Invest</u>., 1991, <u>21</u>, 512-520; 
				Nogawa, K. <u>et al</u>.: Serum vitamin D metabolites in 
				cadmium-exposed persons with renal damage. <u>Int</u>. <u>Arch</u>.
				<u>Occup</u>. <u>Environ</u>. <u>Health</u>, 1990, <u>62</u>, 
				189-193; No­ga­wa, K. <u>et al</u>.: Mechanism for bone disease 
				found in inhabitants environmentally exposed to cadmium: 
				decreased serum 1<i>alpha</i>,25-dihydroxyvitamin D level. <u>
				Int</u>. <u>Arch</u>. <u>Oc­cup</u>. <u>Environ</u>. <u>Health</u>, 
				1987, <u>59</u>, 21-30; Mahaffey, K.R.: Biotoxicity of lead: 
				influence of various factors. <u>Fed</u>. <u>Proc</u>., 1983, <u>
				42</u>, 1730-1734; &nbsp;Smith, C.M. <u>et al</u>.: Ef­fect of lead 
				ingestion on functions of vitamin D and its metabolites. <u>J</u>.
				<u>Nutr</u>., 1981, <u>111</u>, 1321-1329; Rosen, J.F. <u>et al</u>.: 
				Reduction in 1,25-di­hyd­ro­xy­vi­ta­min D in children with 
				increased lead absorbtion. <u>N</u>. <u>Eng</u>. <u>J</u>. <u>
				Med</u>., 1980, <u>302</u>, 1128-1131; Lorentzon, R. and S.E. 
				Larson: Vitamin D metabolism in adult rats at low and normal 
				calcium intake and the effect of cad­mi­um exposure. <u>Clin</u>.
				<u>Sci</u>. <u>Mol</u>. <u>Med</u>., 1977, <u>53</u>, 439-446.
				</span></div>
			<div style="mso-element:footnote" id="ftn88">
				<p class="MsoFootnoteText">
				<a name="_ftn88" title href="#_ftnref88">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[88]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Cam­pag­na, D. <u>et al</u>.: Negative re­lationships bet­ween 
				eryth­ro­cyte Ca-pump activity and lead levels in mo­thers and 
				newborns. <u>Life Sci</u>., 2000, <u>68</u>, 203-215; Freitas, 
				A.J. <u>et al</u>.: Ef­fects of Hg<sup>2+</sup> and CH<sub>3</sub>Hg<sup>+</sup> 
				on Ca<sup>2+</sup> fluxes in rat brain mic­ro­so­mes. <u>Brain 
				Res</u>., 1996, <u>738</u>, 257-264; Yal­la­pragada, P.R. <u>et 
				al</u>.: In­hibition of cal­cium trans­port by mer­cu­ry salts 
				in rat ce­rebellum and cerebral cortex <i>in vitro</i>. <u>J</u>.
				<u>Appl</u>. <u>To­xi­co</u>l., 1996, <u>16</u>, 325-330; 
				Hech­­ten­berg, S. and D. Beyers­­mann: In­hi­bi­tion of 
				sarcoplasmic reticulum Ca<sup>2+</sup>-ATP­ase activity by 
				cad­mi­um, lead and mer­cury. <u>Enzyme</u>, 1991, <u>45</u>, 
				109-115; Shah, J. and H.C. Pant: Effect of cad­mi­um on Ca<sup>2+</sup> 
				transport in brain mic­ro­so­mes. <u>Brain Res</u>., 1991, <u>
				566</u>, 127-130; Zhang, G.H. <u>et al</u>.: Ef­fects of heavy 
				me­tal on rat liver mic­ro­so­mal Ca<sup>2+</sup>-ATPase and Ca<sup>2+</sup> 
				seques­te­ring. Re­la­tion to SH groups. <u>J</u>. <u>Biol</u>.
				<u>Chem</u>., 1990, <u>265</u>, 2184-2189; Verbost, P. M. <u>et 
				al</u>.: Cadmium inhibits plasma membrane cal­cium trans­port.
				<u>J</u>. <u>Membr</u>. <u>Biol</u>., 1988, <u>102</u>, 97-104; 
				Verbost, P.M., M.H. Senden and C.H. van Os: Nano­mo­lar 
				concen­tra­tions of Cd<sup>2+</sup> inhibit Ca<sup>2+</sup> 
				transport systems in plasma mem­branes and int­racellular Ca<sup>2+</sup> 
				sto­res in intestinal epithe­li­um. <u>Bio­chim</u>. <u>Bio­phys</u>.
				<u>Acta</u>, 1987, <u>902</u>, 247-252; Su­mi­da, M. <u>et al</u>.: 
				Ca<sup>2+</sup>,Mg<sup>2+</sup>-ATPase of microsomal membranes 
				from bovine aortic smooth muscle: effects of Sr<sup>2+ </sup>and 
				Cd<sup>2+ </sup>on Ca<sup>2+</sup> uptake and formation of the 
				phosphorylated inter­me­dia­tes of the Ca<sup>2+</sup>,Mg<sup>2+</sup>-ATP­ase.
				<u>J</u>. <u>Bio­chem.</u> (To­kyo), 1986, <u>100</u>, 765-772; 
				Ban­sal, S.K., R.C. Murthy and</span><span lang="EN-GB" style="font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				S.V. Chandra: The effects of some divalent metals on cardiac and 
				branchial Ca<sup>2+</sup>-ATPase in a freshwater fish <i>
				Saccobranchus fossilis</i>. <u>Ecotoxicol</u>. <u>En­vi­ron</u>.
				<u>Saf</u>., 1985, <u>9</u>, 373-377; Thompson, J.D. and B.R. 
				Ne­chay: Inhibition by metals of a canine renal 
				cal­ci­um,mag­ne­sium-activated adenosine­tri­phos­phatase. <u>J</u>.
				<u>Toxicol</u>. <u>Environ</u>. <u>Health</u>, 1981, <u>7</u>, 
				901-908; Berg, G. and E.F. Miles: Mechanism of inhibition of 
				active transport ATPases by mercurials. <u>Chem</u>. <u>Biol</u>.
				<u>Interact</u>., 1979, <u>27</u>, 199-219.</span></div>
			<div style="mso-element:footnote" id="ftn89">
				<p class="MsoFootnoteText">
				<a name="_ftn89" title href="#_ftnref89">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[89]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Ghijser, W.E. and C.H. van Os: 1 <i>alpha</i>, 
				25-Di­hyd­ro­xy-vi­ta­min-D-3 re­gu­lates ATP-de­pen­dent 
				calcium trans­port via basolateral plasma mem­branes of rat 
				ente­ro­cytes. <u>Biochim</u>. <u>Bio­phys</u>. <u>Acta</u>, 
				1982, 689, 170-172.</span></div>
			<div style="mso-element:footnote" id="ftn90">
				<p class="MsoFootnoteText">
				<a name="_ftn90" title href="#_ftnref90">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[90]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Smith, C.M. <u>et al</u>.: Effect of lead in­ges­tion on 
				func­tions of vi­ta­min D and its me­ta­bo­li­tes. <u>J</u>. <u>
				Nutr</u>., 1981, <u>111</u>, 1321-1329. </span></div>
			<div style="mso-element:footnote" id="ftn91">
				<p class="MsoFootnoteText">
				<a name="_ftn91" title href="#_ftnref91">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[91]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Liu, X.Y., T.Y. Jin and G.F. Nordberg: Increased urinary calcium 
				and mag­ne­sium excretion in rats injected with mercuric 
				chloride. <u>Pharmacol</u>. <u>Toxicol</u>., 1991, <u>68</u>, 
				254-259.</span></div>
			<div style="mso-element:footnote" id="ftn92">
				<p class="MsoFootnoteText">
				<a name="_ftn92" title href="#_ftnref92">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[92]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Leffler, P., T.Y. Yin and G.F. Nordberg: 
				Cadmium-metallo­thionein-induced kidney dysfunction in­crea­ses 
				magnesium excretion in the rat. <u>Toxicol</u>. <u>Appl</u>. <u>
				Pharmacol</u>., 1990, <u>103</u>, 180-184; Fowler, B.A., P.L. 
				Goering and K.S. Squibb: Mechnism of 
				cadmium-metallothionein-induced nephrotoxicity: relationship to 
				altered renal cal­cium metabolism. <u>Experientia Suppl</u>., 
				1987, <u>52</u>, 661-668; Jin, T.Y., P. Leffler and G.F. 
				Nordberg: Cad­mi­um-metallothionein nephrotoxicity in the rat: 
				transient calciuria and proteinuria. <u>Toxico­logy</u>, 1987,
				<u>45</u>, 307-317. </span></div>
			<div style="mso-element:footnote" id="ftn93">
				<p class="MsoFootnoteText">
				<a name="_ftn93" title href="#_ftnref93">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[93]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Wang, H. <u>et al</u>.: Influence of en­vi­ronmental cad­mium on 
				forearm bone density. <u>J</u>. <u>Bone Miner</u>. <u>Res</u>., 
				2003, <u>18</u>, 553-560; Alfvén, T. <u>et al</u>.: Low-level 
				cad­mi­um exposure and osteoporosis. <u>J</u>. <u>Bone Miner</u>.
				<u>Res</u>., 2000, <u>15</u>, 1579-1586; Staes­sen, J.A. <u>et 
				al</u>.: Envi­ron­mental expo­su­re to cadmium, fore­arm bone 
				density, and risk of frac­tures: pros­pective population study. 
				Pub­lic Health and Environmental Ex­po­sure to Cad­mi­um 
				(PheeCad) Study Group. <u>Lancet</u>, 1999, <u>353</u>, 
				1140-1144.</span></div>
			<div style="mso-element:footnote" id="ftn94">
				<p class="MsoFootnoteText">
				<a name="_ftn94" title href="#_ftnref94">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[94]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Sirola, J. <u>et al</u>.: Smo­king may impair the bone 
				protective effect of nutritional calcium: a population-based 
				ap­proach. <u>J</u>. <u>Bone Mi­ner</u>. <u>Res</u>., 2003, <u>
				18</u>, 1036-1042; Need, A.G. <u>et al</u>.: Relationships 
				between intestinal calcium ab­sorbtion, serum vitamin D 
				metabolites and smoking in post­me­nopausal women. <u>Osteoporos</u>.
				<u>Int</u>., 2002, <u>13</u>, 83-88; Rapuri, P.B. <u>et al</u>.: 
				Smoking and bone meta­bo­lism in elderly women. <u>Bone</u>, 
				2000, <u>27</u>, 429-436; Krall, E.A. and B. Dawson-Hughes: 
				Smoking increases bone loss and decreases in­tes­tinal calcium 
				ab­sorb­tion. <u>J</u>. <u>Bone Mi­ner</u>. <u>Res</u>., 1999,
				<u>14</u>, 215-220; Krall, E.A. and B. Dawson-Hughes:&nbsp; Smoking 
				and bone loss among post­me­no­pau­sal women. <u>J</u>. <u>Bone 
				Miner</u>. <u>Res</u>., 1991, <u>6</u>, 331-338.</span></div>
			<div style="mso-element:footnote" id="ftn95">
				<p class="MsoFootnoteText">
				<a name="_ftn95" title href="#_ftnref95">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[95]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				El-Agha, O. and I.G. Gokmen: Smo­king habits and cad­mi­um 
				intake in Turkey. <u>Biol</u>. <u>Trace Elem</u>. <u>Res</u>., 
				2002, <u>88</u>, 31-43; Guo, R. and X. Jiang: [Mo­ni­to­ring on 
				blood lead and cadmium in Nanjing inhabitants from 1983 to 1998] 
				[Ar­tic­le in Chi­ne­se]. <u>Wei Sheng&nbsp; Yan Jiu</u>, 2000, <u>29</u>, 
				32-33; Baecklund, M. <u>et al</u>.: Variations in blood 
				con­centrations of cadmium and lead in the elderly. <u>Environ</u>.
				<u>Res</u>., 1999, <u>80</u>, 222-230; dell’Omo, M. <u>et al</u>.: 
				Blood cadmium concentrations in the general population of 
				Umbria, central Italy. <u>Sci</u>. <u>Total Env</u>., 1999, <u>
				226</u>, 57-64; Qu, J.B. <u>et al</u>.: Blood lead and cadmium 
				in a general population in Jinan City, Chi­na. <u>Int</u>. <u>
				Arch</u>. <u>Occup</u>. <u>En­vi­ron</u>. <u>Health</u>, 1993,
				<u>65</u> (1 Suppl.), S201-S204; Elinder, G.C. <u>et al</u>.: 
				Lead and cadmium levels in blood samples from the general 
				population of Sweden. <u>En­vi­ron</u>. <u>Res</u>., 1983, <u>30</u>, 
				233-253.</span></div>
			<div style="mso-element:footnote" id="ftn96">
				<p class="MsoFootnoteText">
				<a name="_ftn96" title href="#_ftnref96">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[96]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Nakagawa, R.: Concentration of mercury in hair of diseased 
				people in Japan. <u>Chemosphere</u>, 1995, <u>30</u>, 135-140.</span></div>
			<div style="mso-element:footnote" id="ftn97">
				<p class="MsoFootnoteText">
				<a name="_ftn97" title href="#_ftnref97">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[97]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Nakagawa, 1995, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn98">
				<p class="MsoFootnoteText">
				<a name="_ftn98" title href="#_ftnref98">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[98]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See: Meyer, H.E. <u>et al</u>.: Height and body mass index in 
				Oslo, Norway, compared to other regions of Europe: do they 
				explain differences in the incidence of hip fracture? European 
				Vertebral Osteoporosis Study Group. <u>Bone</u>, 1995, <u>17</u>, 
				347-350.</span></div>
			<div style="mso-element:footnote" id="ftn99">
				<p class="MsoFootnoteText">
				<a name="_ftn99" title href="#_ftnref99">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[99]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian, A. <u>et al</u>.: Estimation of the net acid load of 
				the diet of ancestral preagricultural <i>Homo sapiens</i> and 
				their hominid ancestors. <u>Am</u>. <u>J</u>. <u>Clin</u>. <u>
				Nutr</u>., 2002, <u>76</u>, 1308-1316.</span></div>
			<div style="mso-element:footnote" id="ftn100">
				<p class="MsoFootnoteText">
				<a name="_ftn100" title href="#_ftnref100">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[100]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian <u>et al</u>., 2002, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn101">
				<p class="MsoFootnoteText">
				<a name="_ftn101" title href="#_ftnref101">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[101]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Eidlitz, K.: <b><i>Food and emergency foods in the circumpolar 
				area</i></b>. <u>Studia ethnographica Upsaliensis 32</u>, 
				Uni­versity of Uppsala, Uppsala 1969; Eidlitz, K.: <b><i>Föda</i></b>
				<b><i>och nödföda – hur människan använde vildmarkens 
				till­gångar</i></b> [Food and emergency food – how humans were 
				utilizing the resources of the wilderness] [Swedish book]. LT, 
				Stockholm 1971.</span></div>
			<div style="mso-element:footnote" id="ftn102">
				<p class="MsoFootnoteText">
				<a name="_ftn102" title href="#_ftnref102">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[102]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Eidlitz, 1971, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn103">
				<p class="MsoFootnoteText">
				<a name="_ftn103" title href="#_ftnref103">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[103]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Eidlitz, 1971, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn104">
				<p class="MsoFootnoteText">
				<a name="_ftn104" title href="#_ftnref104">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[104]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Eidlitz, 1971, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn105">
				<p class="MsoFootnoteText">
				<a name="_ftn105" title href="#_ftnref105">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[105]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Eidlitz, 1971, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn106">
				<p class="MsoFootnoteText">
				<a name="_ftn106" title href="#_ftnref106">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[106]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See: Koivistoinen, P. (Ed.): <b><i>Mineral Element Composition 
				of Finnish Foods: N, K, Ca, Mg, P, S, Fe, Cu, Mn, Zn, Mo, Co, 
				Ni, Cr, F, Se, Si, Rb, Al, B, Br, Hg, A, C, Pb, and Ash.</i></b>
				<u>Acta Agriculturae Scan­dinavica</u>, <u>Supplementum 22</u>. 
				Stockholm, Sweden 1980.</span></div>
			<div style="mso-element:footnote" id="ftn107">
				<p class="MsoFootnoteText">
				<a name="_ftn107" title href="#_ftnref107">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[107]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Morgeli, C. and S. Schulz: [Re­peat caesarean delivery by the 
				Zürich city wound physician Johann Jakob Locher 1817/1818] 
				[Article in Ger­man]. <u>Gesnerus</u>, 1996, 53, 194-216.</span></div>
			<div style="mso-element:footnote" id="ftn108">
				<p class="MsoFootnoteText">
				<a name="_ftn108" title href="#_ftnref108">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[108]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Schober-Flores, C.: The sun’s damaging effects. <u>Dermatol</u>.
				<u>Nurs</u>., 2001, <u>13</u>, 279-286.</span></div>
			<div style="mso-element:footnote" id="ftn109">
				<p class="MsoFootnoteText">
				<a name="_ftn109" title href="#_ftnref109">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[109]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Schober-Flores, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn110">
				<p class="MsoFootnoteText">
				<a name="_ftn110" title href="#_ftnref110">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[110]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Sleijffers, A.: UVB exposure impairs immune responses after 
				hepatitis B vaccination in two different mouse strains. <u>
				Photochem</u>. <u>Pho­to­biol</u>., 2002, <u>75</u>, 541-546; 
				Beissert, S. and T. Schwarz: Me­cha­nisms in­vol­ved in 
				ult­ra­violet light-in­du­ced im­­mu­no­sup­pres­sion. <u>J</u>.
				<u>In­ves­tig</u>. <u>Dermatol</u>. <u>Symp</u>. <u>Proc</u>., 
				1999, <u>4</u>, 61-64; Lu­ger, T.A. <u>et al</u>.: Role of 
				epi­dermal cell-de­ri­ved <i>alpha</i>-me­la­no­cy­te 
				stimulating hor­mo­ne in ultraviolet light me­dia­ted local 
				im­mu­no­sup­pres­sion. <u>Ann</u>. <u>N</u>. <u>Y</u>. <u>Acad</u>.
				<u>Sci</u>., 1999, <u>885</u>, 209-216; Cly­desdale, G.J., G.W. 
				Dan­die and H.K.&nbsp; Müller: Ult­ra­vio­let light induced injury: 
				im­mu­nological and in­flam­matory effects. <u>Im­mu­nol</u>. <u>
				Cell</u>. <u>Biol</u>., 2001, <u>79</u>, 547-568; Garssen, J., 
				T.L. Buckley and H. Van Lo­ve­ren: A role for neu­ro­peptides in 
				UVB-induced sys­te­mic im­mu­nosuppression. <u>Photochem</u>. <u>
				Pho­to­bi­ol</u>., 1998, <u>68</u>, 205-210; Garssen, J. <u>et 
				al</u>.: Estimation of the ef­fect of in­crea­sing UVB exposure 
				on the human im­mu­ne sys­tem and related resistance to 
				infectious diseases and tu­mours. <u>J</u>. <u>Photo­chem</u>.
				<u>Photobiol</u>. <u>B</u>, 1998, <u>42</u>, 167-179; Meu­nier, 
				L., N. Rai­son-Peyron and J. Me­na­di­er: [UV-induced 
				immunosuppression and skin can­­cers] [Article in French]. <u>
				Rev</u>. <u>Med</u>. <u>Interne</u>, 1998, <u>19</u>, 247-254; 
				Schwarz, A. <u>et al</u>.: Interleukin 12 breaks ult­ra­vio­let 
				light induced im­mu­no­sup­pres­sion by affecting CD8<sup>+</sup> 
				rather than CD4<sup>+</sup> T cells. <u>J</u>. <u>Invest</u>. <u>
				Der­ma­tol</u>., 1998, <u>110</u>, 272-276; Schwarz, A. <u>et al</u>.: 
				Ultraviolet light-induced immune tolerance is mediated via the 
				Fas/Fas-ligand system. <u>J</u>. <u>Im­mu­nol</u>., 1998, <u>160</u>, 
				4262-4270; el-Ghorr, A.A. and M. Nor­val: The effect of 
				chro­­­­­nic treatment of mice with urocanic acid isomers. <u>
				Photochem</u>. <u>Photobiol.</u>, 1997, <u>65</u>, 866-872; 
				el-Ghorr, A.A. and M. Nor­val: The role of inter­leu­kin-4 in 
				ultraviolet B light-induced im­mu­no­sup­pres­sion. <u>
				Im­mu­no­lo­gy</u>, 1997, <u>92</u>, 26-32; Garssen, J., R.J. 
				Van­de­briel and H. van Loveren: Molecular as­pects of 
				UVB-induced im­mu­no­sup­pres­sion. <u>Arch</u>. <u>Toxicol</u>.
				<u>Suppl</u>., 1997, <u>19</u>. 97-109; Hurks, H.M. <u>et al</u>.:
				<i>In situ</i> action spectra sug­gest that DNA damage is 
				involved in ult­ra­vio­let radiation-induced immunosuppression 
				in hu­mans. <u>Pho­to­chem</u>. <u>Pho­to­bi­o</u>l., 1997, <u>
				66</u>, 76-81;&nbsp; Strick­land, F.M. and M.L. Kripke: Immune 
				response as­so­cia­ted with non­me­la­no­ma skin cancer. <u>Clin</u>.
				<u>Plast</u>. <u>Surg</u>., 1997, <u>24</u>, 637-647; Hurks, 
				H.M. <u>et al</u>.: The action spectra for UV-induced 
				sup­pression of MLR and MECLR show that immu­no­sup­pression is 
				mediated by DNA damage. <u>Photochem</u>. <u>Pho­to­biol</u>., 
				1995, <u>62</u>, 449-453. </span></div>
			<div style="mso-element:footnote" id="ftn111">
				<p class="MsoFootnoteText">
				<a name="_ftn111" title href="#_ftnref111">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[111]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Schober-Flores, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn112">
				<p class="MsoFootnoteText">
				<a name="_ftn112" title href="#_ftnref112">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[112]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Goldenberg, L.A.: The sun and skin can­cer. What you need to 
				know about diag­nosis and treatment. <u>North­west</u>. <u>Dent</u>., 
				2000, <u>79</u>, 19-25.</span></div>
			<div style="mso-element:footnote" id="ftn113">
				<p class="MsoFootnoteText">
				<a name="_ftn113" title href="#_ftnref113">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[113]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Gol­den­berg, 2000, <i>op. cit.</i>; English, D.R. <u>et al</u>.: 
				Sunlight and cancer. <u>Cancer Causes Control</u>, 1997, <u>8</u>, 
				271-283; Osterlind, A.: Cancer and UV-radiation. <u>Pharmacol</u>.
				<u>Toxicol</u>., 1993, <u>72</u> Suppl. 1, 67-68.</span></div>
			<div style="mso-element:footnote" id="ftn114">
				<p class="MsoFootnoteText">
				<a name="_ftn114" title href="#_ftnref114">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[114]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Branda, F.R. and J.W. Eaton: Skin color and nutrient photolysis: 
				an evolutionary hypothesis. <u>Science</u>, 1978, <u>201</u>, 
				625-626.</span></div>
			<div style="mso-element:footnote" id="ftn115">
				<p class="MsoFootnoteText">
				<a name="_ftn115" title href="#_ftnref115">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[115]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Branda and Eaton, 1978, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn116">
				<p class="MsoFootnoteText">
				<a name="_ftn116" title href="#_ftnref116">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[116]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Branda and Eaton, 1978, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn117">
				<p class="MsoFootnoteText">
				<a name="_ftn117" title href="#_ftnref117">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[117]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Steegers-Theunissen, R.P.: Folate meta­bolism and neural tube 
				defects: a review. <u>Eur</u>. <u>J</u>. <u>Obstet</u>. <u>
				Gynecol</u>. <u>Reproduc</u>. <u>Biol</u>., 1995, <u>61</u>, 
				39-48; Branda and Eaton, 1978, <i>op. cit</i>.</span></div>
			<div style="mso-element:footnote" id="ftn118">
				<p class="MsoFootnoteText">
				<a name="_ftn118" title href="#_ftnref118">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[118]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Branda and Eaton, 1978, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn119">
				<p class="MsoFootnoteText">
				<a name="_ftn119" title href="#_ftnref119">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[119]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Eaton, S.B., L. Cordain and S. Lin­de­berg: Evolutionary health 
				promotion: a con­si­deration of common coun­terarguments. <u>
				Prev</u>. <u>Med</u>., 2002, <u>34</u>, 119-123; Eaton, S.B. <u>
				et al</u>.: Evolutionary health promotion. <u>Prev</u>. <u>Med</u>., 
				2002, <u>34</u>, 109-118; Cor­dain, L. <u>et al</u>.: An 
				evolutionary analysis of the aetio­lo­gy and pathogenesis of 
				juvenile-onset myopia. <u>Acta Ophtal­mol</u>. <u>Scand</u>., 
				2002, <u>80</u>, 125-135; Sebastian, A. <u>et al</u>.: 
				Estimation of the net acid load of the diet of ancestral 
				pre­agricultural <i>Homo sapiens</i> and their hominid 
				an­ces­tors. <u>Am</u>. <u>J</u>. <u>Clin</u>. <u>Nutr</u>., 
				2002, <u>76</u>, 1308-1316; Eaton, S.B. and S.B. Eaton 3<sup>rd</sup>: 
				Paleolithic vs. mo­dern diets – se­lec­ted pathophysiological 
				im­pli­ca­tions. <u>Eur</u>. <u>J</u>. <u>Nutr</u>., 2000, <u>39</u>, 
				67-70; Haenel, H.: Phylogenesis and nutrition. <u>Nahrung</u>, 
				1989, <u>33</u>, 867-887; Eaton, S.B. and M. Konner: Paleolithic 
				nutrition. A consideration of its nature and cur­rent 
				im­pli­cations. <u>N</u>. <u>Engl</u>. <u>J</u>. <u>Med</u>., 
				1985, <u>312</u>, 283-289.</span></div>
			<div style="mso-element:footnote" id="ftn120">
				<p class="MsoFootnoteText">
				<a name="_ftn120" title href="#_ftnref120">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[120]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Cordain, L. <u>et al</u>.: Acne vul­ga­ris: a disease of Western 
				civilization. <u>Arch</u>. <u>Dermatol</u>., 2002, <u>138</u>, 
				1584-1590; Lindeberg, S. <u>et al</u>.: Low se­rum insulin in 
				tra­di­tio­nal Pacific Is­lan­ders – the Kitava Study. <u>
				Metabolism</u>, 1999, <u>48</u>, 1216-1219; Lindeberg, S. <u>et 
				al</u>.: Age relations of cardiovascular risk fac­tors in a 
				tra­ditional Melanesian society: the Kitava study. <u>Am</u>. <u>
				J</u>. <u>Clin</u>. <u>Nutr</u>., 1997, <u>66</u>, 845-852; 
				Lin­de­berg, S. <u>et al</u>.: Car­dio­vascular risk fac­tors in 
				a Melanesian po­pu­la­tion apparently free from stroke and 
				ischaemic heart disease: the Kitava stu­dy. <u>J</u>. <u>Intern</u>.
				<u>Med</u>., 1994, <u>236</u>, 331-340; Lindeberg, S. and B. 
				Lundh: Apparent absence of stroke and ischaemic heart disease in 
				a traditional Me­la­nesian island: a cli­ni­cal study in Kitava.
				<u>J</u>. <u>Intern</u>. <u>Med</u>., 1993, <u>233</u>, 269-275.</span></div>
			<div style="mso-element:footnote" id="ftn121">
				<p class="MsoFootnoteText">
				<a name="_ftn121" title href="#_ftnref121">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[121]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Eaton and Eaton, 2000, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn122">
				<p class="MsoFootnoteText">
				<a name="_ftn122" title href="#_ftnref122">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[122]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Boot, G.L. and E.E. Wang: Preventive health care, 2000 up­da­te: 
				screening and management of hyper­ho­mo­cysteinemia for the 
				prevention of coronary artery disease events. The Canadian Task 
				Force on Preventive Health Care. <u>CMAJ</u>, 2000, <u>163</u>, 
				21-29; Chambers, J.C. <u>et al</u>.: Im­pro­ved vascular 
				endothelial function after oral B vi­ta­mins. An effect mediated 
				through reduced con­cen­trations of free plasma homocysteine. <u>
				Cir­cu­la­tion</u>, 2000, <u>102</u>, 2479-2483; Chambers, J.C.
				<u>et al</u>.: Plasma ho­mo­cys­tei­ne concentrations and risk 
				of coronary heart disease in UK Indian Asian and European men.
				<u>Lan­cet</u>, 2000, <u>355</u>, 523-527; Mar­cuc­ci, R. <u>et 
				al</u>.: Tissue factor and homo­cys­tei­ne levels in ischemic 
				heart disease are as­so­cia­ted with angio­gra­phi­cal­ly 
				documented clinical recurrences after co­ronary angioplasty. <u>
				Thromb</u>. <u>Hae­most</u>., 2000, <u>83</u>, 826-832.</span></div>
			<div style="mso-element:footnote" id="ftn123">
				<p class="MsoFootnoteText">
				<a name="_ftn123" title href="#_ftnref123">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[123]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Kim, Y.I. <u>et al</u>.: Severe folate deficiency impairs 
				natural killer cell-mediated cytotoxicity in rats. <u>J</u>. 
				Nutr., 2002, 132, 1361-1367; Dhur, A., P. Galan and S. Hercberg: 
				Folate status and the immune system. <u>Prog</u>. <u>Food Nutr</u>.
				<u>Sci</u>., 1991, <u>15</u>, 43-60.</span></div>
			<div style="mso-element:footnote" id="ftn124">
				<p class="MsoFootnoteText">
				<a name="_ftn124" title href="#_ftnref124">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[124]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Dhur, Galan and Hercberg, 1991, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn125">
				<p class="MsoFootnoteText">
				<a name="_ftn125" title href="#_ftnref125">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[125]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Dhur, Galan and Hercberg, 1991, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn126">
				<p class="MsoFootnoteText">
				<a name="_ftn126" title href="#_ftnref126">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[126]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Lehninger, A.L.: <b><i>Principles of Bio­che­mist­ry.</i></b> 
				Worth Publishers, Inc., New York 1982.</span></div>
			<div style="mso-element:footnote" id="ftn127">
				<p class="MsoFootnoteText">
				<a name="_ftn127" title href="#_ftnref127">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[127]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Lehninger, 1982, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn128">
				<p class="MsoFootnoteText">
				<a name="_ftn128" title href="#_ftnref128">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[128]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Lehninger, 1982, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn129">
				<p class="MsoFootnoteText">
				<a name="_ftn129" title href="#_ftnref129">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[129]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Lehninger, 1982, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn130">
				<p class="MsoFootnoteText">
				<a name="_ftn130" title href="#_ftnref130">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[130]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Lehninger, 1982, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn131">
				<p class="MsoFootnoteText">
				<a name="_ftn131" title href="#_ftnref131">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[131]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Lehninger, 1982, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn132">
				<p class="MsoFootnoteText">
				<a name="_ftn132" title href="#_ftnref132">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[132]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Hardman, J.G., L.E. Lim­bird and A. Goodman Gilman (Eds.): <b>
				<i>Goodman &amp; Gilman’s The Pharmacological Basis of 
				The­ra­peu­tics.</i></b> Tenth Edition. The McGraw-Gill 
				Companies, Inc., New York 2001; Lehninger, 1982, <i>op. cit</i>.</span></div>
			<div style="mso-element:footnote" id="ftn133">
				<p class="MsoFootnoteText">
				<a name="_ftn133" title href="#_ftnref133">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[133]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Hardman, Limbird and Goodman Gilman, 2001, <i>op. cit.</i>; 
				Lehninger, 1982, <i>op. cit</i>.</span></div>
			<div style="mso-element:footnote" id="ftn134">
				<p class="MsoFootnoteText">
				<a name="_ftn134" title href="#_ftnref134">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[134]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Hardman, Limbird and Goodman Gilman, 2001, <i>op. cit.</i>: 
				Lehninger, 1982, <i>op. cit</i>.</span></div>
			<div style="mso-element:footnote" id="ftn135">
				<p class="MsoFootnoteText">
				<a name="_ftn135" title href="#_ftnref135">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[135]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Hardman, Limbird and Goodman Gilman, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn136">
				<p class="MsoFootnoteText">
				<a name="_ftn136" title href="#_ftnref136">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[136]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Hardman, Limbird and Goodman Gilman, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn137">
				<p class="MsoFootnoteText">
				<a name="_ftn137" title href="#_ftnref137">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[137]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Leh­nin­ger, 1982, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn138">
				<p class="MsoFootnoteText">
				<a name="_ftn138" title href="#_ftnref138">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[138]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Leh­nin­ger, 1982, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn139">
				<p class="MsoFootnoteText">
				<a name="_ftn139" title href="#_ftnref139">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[139]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See: Sebastian, A. <u>et al</u>.: Estimation of the net acid 
				load of the diet of ancestral preagricultural <i>Homo sapiens</i> 
				and their hominid ancestors. <u>Am</u>. <u>J</u>. <u>Clin</u>.
				<u>Nutr</u>., 2002, <u>76</u>, 1308-1316.</span></div>
			<div style="mso-element:footnote" id="ftn140">
				<p class="MsoFootnoteText">
				<a name="_ftn140" title href="#_ftnref140">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[140]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Sebastian <u>et al</u>., 2002, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn141">
				<p class="MsoFootnoteText">
				<a name="_ftn141" title href="#_ftnref141">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[141]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Hardman, J.G., L.E. Lim­bird and A. Goodman Gilman (Eds.): <b>
				<i>Goodman &amp; Gilman’s The Pharmacological Basis of 
				The­ra­peu­tics.</i></b> Tenth Edition. The McGraw-Gill 
				Companies, Inc., New York 2001.</span></div>
			<div style="mso-element:footnote" id="ftn142">
				<p class="MsoFootnoteText">
				<a name="_ftn142" title href="#_ftnref142">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[142]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Hardman, Limbird and Goodman Gilman, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn143">
				<p class="MsoFootnoteText">
				<a name="_ftn143" title href="#_ftnref143">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[143]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Hardman, Limbird and Goodman Gilman, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn144">
				<p class="MsoFootnoteText">
				<a name="_ftn144" title href="#_ftnref144">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[144]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Hardman, Limbird and Goodman Gilman, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn145">
				<p class="MsoFootnoteText">
				<a name="_ftn145" title href="#_ftnref145">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[145]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Hardman, Limbird and Goodman Gilman, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn146">
				<p class="MsoFootnoteText">
				<a name="_ftn146" title href="#_ftnref146">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[146]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Hardman, Limbird and Goodman Gilman, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn147">
				<p class="MsoFootnoteText">
				<a name="_ftn147" title href="#_ftnref147">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[147]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Hardman, Limbird and Goodman Gilman, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn148">
				<p class="MsoFootnoteText">
				<a name="_ftn148" title href="#_ftnref148">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[148]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				For information about how treatment with too low or too 
				irregular doses of antimicrobial drugs may enhance the risk of 
				drug resistance evo­lu­tion, see: Levy, S.B.: <b><i>The 
				Antibiotic Paradox.</i></b> <i>How Miracle Drugs Are Des­troying 
				the Miracle.</i> Plenum Press, New York and London 1992; for 
				information about multiresistant tuber­cu­lo­sis, see: Reichman, 
				L.B. with J. Hop­kins Tanne: <b><i>Timebomb.</i></b> <i>The 
				Global Epidemic of Multi-Drug-Resistant Tuberculosis.</i> 
				McGraw-Hill, New York 2002.</span></div>
			<div style="mso-element:footnote" id="ftn149">
				<p class="MsoFootnoteText">
				<a name="_ftn149" title href="#_ftnref149">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[149]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Duthie, S.J. <u>et al</u>.: Impact of folate deficiency on DNA 
				sta­bi­lity. <u>J</u>. <u>Nutr</u>., 2002, <u>132</u> (8 
				Suppl.), 2444S-2449S; Ames, B.N.: DNA damage from 
				mic­ro­nut­rient deficiencies is likely to be a major cause of 
				cancer. <u>Mutat</u>. <u>Res</u>., 2001, <u>475</u>, 7-20; 
				Duthie, S.J. <u>et al</u>.: Fo­la­te deficiency <i>in vitro</i> 
				induces uracil misincorporation and DNA hy­po­me­thy­lation and 
				inhibits DNA ex­ci­sion re­pair in immortalized normal human 
				colon epithelial cells. <u>Nutr</u>. <u>Can­cer</u>, 2000, <u>37</u>, 
				245-251; Ames, B.N.: Mic­ronutrient defi­cien­cies. A ma­jor 
				cause of DNA damage. <u>Ann</u>. <u>N</u>. <u>Y</u>. <u>Acad</u>.
				<u>Sci</u>., 1999, <u>889</u>, 87-106; Duthie, S.J.: Folic acid 
				deficiency and cancer: me­chanisms of DNA instability. <u>Br</u>.
				<u>Med</u>. <u>Bull</u>., 1999, <u>55</u>, 578-592; Melnyk, S.
				<u>et al</u>.: Uracil mis­in­cor­po­ra­tion, DNA strand breaks, 
				and gene amplification are as­so­cia­ted with tumorigenic cell 
				trans­for­ma­tion in fo­la­te defi­ci­ent/re­pleted Chinese 
				hamster ovary cells. <u>Can­cer Lett</u>., 1999, <u>146</u>, 
				35-44; Blount, B.C. <u>et al</u>.: Folate deficiency causes 
				uracil mis­in­cor­po­ration into human DNA and chromosome 
				breakage: im­pli­ca­tions for cancer and neuronal damage. <u>
				Proc</u>. <u>Natl</u>. <u>Acad</u>. <u>Sci</u>. <u>USA</u>, 
				1997, <u>94</u>, 3290-3295.</span></div>
			<div style="mso-element:footnote" id="ftn150">
				<p class="MsoFootnoteText">
				<a name="_ftn150" title href="#_ftnref150">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[150]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Blount <u>et al</u>., 1997, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn151">
				<p class="MsoFootnoteText">
				<a name="_ftn151" title href="#_ftnref151">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[151]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Blount <u>et al</u>., 1997, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn152">
				<p class="MsoFootnoteText">
				<a name="_ftn152" title href="#_ftnref152">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[152]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Ames, 2001, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn153">
				<p class="MsoFootnoteText">
				<a name="_ftn153" title href="#_ftnref153">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[153]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See: Weinberg, R.A.: How cancer arises. <u>Sci</u>. <u>Am</u>., 
				1996, <u>275</u> (3), 62-70.</span></div>
			<div style="mso-element:footnote" id="ftn154">
				<p class="MsoFootnoteText">
				<a name="_ftn154" title href="#_ftnref154">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[154]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Liu, J. <u>et al</u>.: De­lay­ing brain mitochondrial decay and 
				aging with mitochondrial antioxidants and metabolites. <u>Ann</u>.
				<u>N</u>. <u>Y</u>. <u>Acad</u>. <u>Sci</u>., 2002, <u>959</u>, 
				133-166; Wallace, D.C.: Mitochondrial DNA in aging and disease.
				<u>Scientific American</u>, 1997 August, <u>277</u> (2), 40-47.</span></div>
			<div style="mso-element:footnote" id="ftn155">
				<p class="MsoFootnoteText">
				<a name="_ftn155" title href="#_ftnref155">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[155]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Wallace, 1997, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn156">
				<p class="MsoFootnoteText">
				<a name="_ftn156" title href="#_ftnref156">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[156]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See: Ames, B.N.: Micronutrients prevent cancer and delay aging.
				<u>Toxicol</u>. <u>Lett</u>., 1998, <u>102-103</u>, 5-18.</span></div>
			<div style="mso-element:footnote" id="ftn157">
				<p class="MsoNormal" style="line-height: 12.0pt">
				<a name="_ftn157" title href="#_ftnref157">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[157]</span></span></a><span lang="EN-GB" style="font-family: Times New Roman"> 
				For information about genotoxic effects of zidovudine and 
				similar drugs, see: </span>
				<span style="font-family: Times New Roman">Olivero, O.A. <u>et 
				al</u>.: Trans­­­pla­cental ge­no­to­xicity of combined 
				antiretroviral nucleoside ana­logue therapy in <i>Erythrocebus</i>
				<i>patas</i> mon­keys. <u>J</u>. <u>Acquir</u>. <u>Im­mu­ne 
				De­fic</u>. <u>Syndr</u>., 2002, <u>29</u>, 323-329; von 
				Tungeln, L.S. <u>et al</u>.: Frequency of Tk and Hprt 
				lym­pho­cyte mutants and bone marrow micronuclei in B6C3F1/Tk+/- 
				mice trea­ted neonatally with zidovudine and lami­vu­dine. <u>
				Carcinogenesis</u>, 2002, <u>23</u>, 1427-1432; Bialkowska, A.
				<u>et al</u>.: Oxi­dative DNA da­ma­ge in fe­tal tissues after 
				trans­pla­cental ex­posure to 3’-azido-3’-deoxythymidine (AZT).
				<u>Car­ci­no­ge­ne­sis</u>, 2000, <u>21</u>, 1059-1062; Ewings, 
				E.L. <u>et al</u>.: Ge­no­toxic and functional con­se­quen­ces 
				of trans­pla­cental zi­do­vu­di­ne exposure in fetal mon­key 
				brain mito­chond­­ria. <u>J</u>. <u>Acquir</u>. <u>Immune Defic</u>.
				<u>Syndr</u>., 2000, <u>24</u>, 100-105; Meng, Q. <u>et al</u>.: 
				Mu­ta­ge­ni­city and loss of he­te­ro­zygosity at the APRT locus 
				in human lym­pho­blas­toid cells ex­po­sed to 
				3’-azido-3’-de­oxy­thy­midine. <u>Mu­ta­ge­ne­sis</u>, 2000, <u>
				15</u>, 405-410; Meng, Q. <u>et al</u>.: Relationships between 
				DNA incorporation, mutant frequency and loss of 
				he­te­ro­zy­go­si­ty at the TK locus in human lym­pho­blastoid 
				cells exposed to 3’-azido-3’-de­oxy­thy­mi­di­ne. <u>Toxicol</u>.
				<u>Sci.</u>, 2000, <u>54</u>, 322-329; Meng, Q. <u>et al</u>.: 
				Zidovudine-didanosine coexposure po­ten­tiates DNA 
				in­cor­po­ration of zido­vu­dine and mutagenesis in human cells.
				<u>Proc</u>. <u>Natl</u>. <u>Acad</u>. <u>Sci</u>. <u>USA</u>, 
				2000, <u>97</u>, 12667-12671; de la Asun­cion, J.G. <u>et al</u>.: 
				Zi­do­vu­dine (AZT) causes an oxidation of mi­to­chond­rial DNA 
				in mouse liver. <u>He­pa­to­lo­gy</u>, 1999, <u>29</u>, 985-987; 
				Suss­man, H.E. <u>et al</u>.: Genotoxicity of 
				3’-azido-3’-de­oxy­thy­midine in the hu­man lym­pho­blas­to­id 
				cell line, TK6: re­la­tion­ships between DNA incorporation, 
				mu­tant fre­quen­cy, and spec­trum of dele­tion muta­tions in 
				HPRT. <u>Muta</u>t. <u>Res</u>., 1999, <u>429</u>, 249-259; 
				Zhang, Z. <u>et al</u>.: Skin tumorigenesis and Ki-<i>ras</i> 
				and Ha-<i>ras</i> mutations in tumors from adult mice exposed <i>
				in utero </i>to 3’-azido-2’,3’-dideoxythymidine. <u>Mol</u>. <u>
				Car­ci­nog</u>., 1998, <u>23</u>, 45-51; Agarwal, R.P. and O.A. 
				Oli­ve­ro: Ge­no­to­xi­ci­ty and mitochondrial damage in human 
				lym­pho­cy­tic cells chronically exposed to 
				3’-azido-2’,3’-di­de­oxy­thy­mi­di­ne. <u>Mutat</u>. <u>Res</u>., 
				1997, <u>390</u>, 223-231; Olivero, O.A. <u>et al</u>.: 
				Transplacental effects of 3’-azido-2’,3’-di­de­oxy­thy­mi­di­ne 
				(AZT): tumorigenicity in mice and genotoxicity in mice and 
				mon­keys. <u>J</u>. <u>Natl</u>. <u>Cancer Inst</u>., 1997, <u>
				89</u>, 1602-1608;&nbsp; Dertinger, S.D., D.K. Torous and K.R. 
				To­met­sko: In­duc­tion of mic­ro­nuc­lei by low doses of 
				azidothymidine (AZT). <u>Mutat</u>. <u>Res</u>., 1996, <u>368</u>, 
				301-307; Olivero, O.A. <u>et al</u>.: Vaginal epithelial DNA 
				damage and expression of pre­neo­plas­tic markers in mice during 
				chronic do­sing with tumorigenic levels of 
				3’-azido-2’,3’-di­de­oxy­thy­mi­di­ne. <u>Cancer Res</u>., 1994,
				<u>54</u>, 6235-6242; Haya­ka­wa, M. <u>et al</u>.: Massive 
				conversion of guanosine to 8-hyd­ro­xy­-guanosine in mouse liver 
				mito­chond­rial DNA by ad­mi­nis­tration of azidothymidine. <u>
				Biochem</u>. <u>Biophys</u>. <u>Res</u>. <u>Commun</u>., 1991,
				<u>176</u>, 87-93. </span></div>
			<div style="mso-element:footnote" id="ftn158">
				<p class="MsoFootnoteText">
				<a name="_ftn158" title href="#_ftnref158">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[158]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				For information about genotoxic (mutagenic) and/or carcinogenic 
				and/or tumor promoter effects of BHT and DHA and about some 
				mechanisms accounting for the geno­toxic effects, see: Oikawa, 
				S. <u>et al</u>.: Oxi­dative DNA damage and apoptosis induced by 
				meta­bolites of butylated hydroxytoluene. <u>Biochem</u>. <u>
				Phar­ma­col</u>., 1998, <u>56</u>, 361-370; Oku­bo, T. <u>et al</u>.: 
				Con­­tri­bution of oxygen ra­di­cals to DNA clea­vage by quinone 
				com­pounds de­ri­­ved from phenolic antioxidants, <i>tert</i>-bu­tyl­hyd­ro­quinone 
				and 2,5-di-<i>tert</i>-butyl­hyd­ro­qui­none. <u>Toxi­­col</u>.
				<u>Lett</u>., 1997, <u>90</u>, 11-18; Nagai, F. <u>et al</u>.: 
				For­ma­tion of 8-hydroxy­de­oxy­gua­nosine in calf thy­mus DNA 
				treated with <i>tert</i>-bu­tyl­­hyd­ro­qui­no­ne, a major 
				meta­bolite of butylated hyd­roxy­ani­sole. <u>To­xi­col</u>. <u>
				Lett</u>., 1996, <u>89</u>, 163-167; Peters, M.M. <u>et al</u>.: 
				Glu­ta­thione conjugates of <i>tert</i>-butyl-hyd­ro­qui­none, a 
				meta­bo­li­te of the urinary tract tumor pro­mo­ter 3-<i>tert</i>-butyl-hyd­roxy­anisole, 
				are toxic to kidney and bladder. <u>Can­cer Res</u>., 1996, <u>
				56</u>, 1006-1011; Schilderman, P.A. <u>et al</u>.: Induction of 
				oxidative DNA damages and enhancement of cell proliferation in 
				human lymphocytes <i>in vitro</i> by butylated 
				hyd­roxy­ani­sole. <u>Carcino­ge­ne­sis</u>, 1995, <u>16</u>, 
				507-512; Nagai, F., K. Ushi­ya­ma and I. Kano: DNA clea­va­ge by 
				metabolites of butylated hyd­ro­xy­to­luene. <u>Arch</u>. <u>
				Toxicol</u>., 1993, <u>67</u>, 552-557;&nbsp;&nbsp; Schil­der­man, P.A. <u>
				et al</u>.: The role of pros­ta­glandin H synthase-me­dia­ted 
				me­ta­bolism in the induc­tion of oxi­dative DNA damage by BHA 
				meta­bo­li­tes. <u>Carci­no­ge­nesis</u>, 1993, <u>14</u>, 
				1297-1302; Berg­mann, B., J.K. Dohr­mann and R. Kahl: For­mation 
				of the semi­quinone anion radical from <i>tert</i>-bu­tylquinone 
				and from <i>tert</i>-butyl­hyd­ro­qui­none in rat liver 
				micro­so­mes. <u>Toxi­cology</u>, 1992, <u>74</u>, 127-133; van 
				Om­men, B. <u>et al</u>.: The glu­ta­thio­ne con­ju­gates of <i>
				tert</i>-butyl hyd­ro­qui­no­ne as potent redox cycling agents 
				and possible reactive agents under­lying the to­xi­ci­ty of 
				buty­lated hyd­roxy­ani­sole. <u>Bio­chem</u>. <u>Bio­phys</u>.
				<u>Res</u>. <u>Commun</u>., 1992, <u>189</u>, 309-314; Thompson, 
				J.A., J.L. Bolton and A.M. Mal­kin­son: Relationship between the 
				meta­bo­lism of bu­ty­la­ted hyd­ro­xy­to­lue­ne (BHT) and lung 
				tumor pro­mo­tion in mice. <u>Exp</u>. <u>Lung Res</u>., 1991,
				<u>17</u>, 439-453; Kahl, R., S. Weinke and H. Kap­pus: 
				Pro­duc­tion of reactive oxygen species due to metabolic 
				activation of butylated hydroxy­ani­sole. <u>To­xi­co­lo­gy</u>, 
				1989, <u>59</u>, 179-194; Phil­lips, B.J. <u>et al</u>.: 
				Mic­rosome-mediated clas­togenicity of butylated 
				hyd­ro­xy­ani­sole (BHA) in cultured Chinese ham­ster ovary 
				cells: the possible role of reactive oxygen species. <u>Mutat</u>.
				<u>Res</u>., 1989, <u>214</u>, 105-114; Thomp­son, D.C. and M.A. 
				Trush: Studies on the mechanism of enhancement of butylated 
				hydroxy­toluene-induced mouse lung to­xi­ci­ty by bu­ty­la­ted 
				hyd­ro­xy­ani­sole. <u>Toxicol</u>. <u>Appl</u>. <u>Pharmacol</u>., 
				1988, <u>96</u>, 122-131; Imaida, K. <u>et al</u>.: Promoting 
				activities of bu­ty­lated hyd­roxy­anisole and butylated 
				hydroxytoluene on 2-stage urinary bladder car­cinogenesis and 
				inhi­bition of <i>gamma</i>-glu­tamyl trans­pep­tidase-positive 
				foci development in the liver of rats. <u>Carcinogenesis</u>, 
				1983, <u>4</u>, 895-899; Witschi, H.R. and C.C. Morse: 
				En­han­cement of lung tumor formation in mice by dietary 
				buty­lated hyd­ro­xy­to­lu­e­ne: dose-time re­la­tion­ships and 
				cell kinetics. <u>J</u>. <u>Natl</u>. <u>Cancer Inst</u>., 1983,
				<u>71</u>, 859-866; Witschi, H.P.: Enhan­ce­ment of tumor 
				formation in mouse lung by dietary buty­lated hyd­ro­xytoluene.
				<u>Toxicology</u>, 1981, <u>21</u>, 95-104;</span><span lang="EN-GB" style="font-size: 10.0pt; font-family: CG Times">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Witschi, H., D. Wil­liamson and S. Lock: Enhancement of urethan 
				tumorigenesis in mouse lung by bu­ty­la­ted hydroxytoluene. <u>J</u>.
				<u>Natl</u>. <u>Cancer Inst</u>., 1977, <u>58</u>, 301-305.</span></div>
			<div style="mso-element:footnote" id="ftn159">
				<p class="MsoFootnoteText">
				<a name="_ftn159" title href="#_ftnref159">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[159]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Can­to­ni, O. <u>et al</u>.: L-histidine-mediated en­han­cement 
				of hydrogen peroxide-induced cytotoxicity: rela­tion­ships 
				between DNA sing­le/doub­le strand breakage and cell killing. <u>
				Pharmacol</u>. <u>Res</u>., 1994, <u>29</u>, 169-178; Ward, 
				J.F., W.F. Blakely and E.L. Joner: Mammalian cells are not 
				killed by DNA single-strand breaks caused by hydroxyl radicals 
				from hydrogen peroxide. <u>Radiat</u>. <u>Res</u>., 1985, <u>103</u>, 
				383-392.</span></div>
			<div style="mso-element:footnote" id="ftn160">
				<p class="MsoFootnoteText">
				<a name="_ftn160" title href="#_ftnref160">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[160]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Dahm-Da­phi, J., C. Sass and W. Alberti: Com­pa­ri­son of 
				biological effects of DNA damage in­du­ced by ionizing 
				ra­dia­tion and hydrogen per­oxi­de in CHO cells. <u>Int</u>. <u>
				J</u>. <u>Radiat</u>. <u>Biol</u>., 2000, <u>76</u>, 67-75; Li, 
				H. and R.W. Byrnes: Association of redox-active iron bound to 
				high mo­le­cu­lar weight structures in nuclei with inhibition of 
				cell growth by H<sub>2</sub>O<sub>2</sub>. <u>Free Radic</u>. <u>
				Biol</u>. <u>Med</u>., 1999, <u>26</u>, 49-60; Jornot, L., H. 
				Petersen and A.F. Junod: Hyd­ro­gen peroxide-induced DNA damage 
				is independent of nuclear calcium but dependent on redox-active 
				ions. <u>Biochem</u>. <u>J</u>., 1998, <u>335</u>, 85-94; 
				Rodriguez, H. <u>et al</u>.: Metal ion-dependent hydrogen 
				peroxide-induced DNA damage is more sequence spe­cific than 
				metal specific. <u>Can­cer Res</u>., 1997, <u>57</u>, 2394-2403.</span></div>
			<div style="mso-element:footnote" id="ftn161">
				<p class="MsoFootnoteText">
				<a name="_ftn161" title href="#_ftnref161">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[161]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Dahm-Daphi, Sass and Al­ber­ti, 2000, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn162">
				<p class="MsoFootnoteText">
				<a name="_ftn162" title href="#_ftnref162">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[162]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Shen, C. and C. Nathan: Nonredundant antioxidant defense by 
				multiple two-cysteine per­oxi­redoxins in human prostate cancer 
				cells. <u>Mol</u>. <u>Med</u>., 2002, <u>8</u>, 95-102; 
				But­terfield, L.H. <u>et al</u>.: From cy­to­pro­tec­tion to 
				tumor suppression: the multifactorial role of peroxiredoxins. <u>
				Anti­oxid</u>. <u>Redox Signal</u>, 1999, 1, 385-402.</span></div>
			<div style="mso-element:footnote" id="ftn163">
				<p class="MsoFootnoteText">
				<a name="_ftn163" title href="#_ftnref163">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[163]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Becker, K. <u>et al</u>.: Thio­re­doxin re­duc­tase as a 
				pathophysiological fac­tor and drug target. <u>Eur</u>. <u>J</u>.
				<u>Biochem</u>., 2000, <u>267</u>, 6118-6125; Gromer, S. <u>et 
				al</u>.: Hu­man placenta thio­re­do­xin re­duc­tase. Isolation 
				of the se­le­no­en­zy­me, steady state ki­ne­tics, and 
				inhibition by the­ra­peu­tic gold com­pounds. </span><u>
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				J</span></u><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">.
				<u>Biol</u>. <u>Chem</u>., 1998, <u>273</u>, 20096-20101.</span></div>
			<div style="mso-element:footnote" id="ftn164">
				<p class="MsoFootnoteText">
				<a name="_ftn164" title href="#_ftnref164">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[164]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Gromer <u>et al, </u>1998, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn165">
				<p class="MsoFootnoteText">
				<a name="_ftn165" title href="#_ftnref165">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[165]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman"> 
				Gromer <u>et al, </u>1998, <i>op. cit.</i></span></div>
			<div style="mso-element:footnote" id="ftn166">
				<p class="MsoFootnoteText">
				<a name="_ftn166" title href="#_ftnref166">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[166]</span></span></a><span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				</span>
				<span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">
				Rayman, M.P.: The ar­gu­ment for increasing selenium intake. <u>
				Proc</u>. <u>Nutr</u>. <u>Soc</u>., 2002, <u>61</u>, 203-215; 
				Rayman, M.P.: The importance of selenium to human health. <u>
				Lancet</u>, 2000, <u>356</u>, 233-241; Rayman, M.P.: Dietary 
				sele­nium: time to act. <u>BMJ</u>, 1997, <u>314</u>, 387-388.</span></div>
			<div style="mso-element:footnote" id="ftn167">
				<p class="MsoFootnoteText">
				<a name="_ftn167" title href="#_ftnref167">
				<span class="MsoFootnoteReference">
				<span lang="NO-BOK" style="font-size: 10.0pt; font-family: Times New Roman">
				[167]</span></span></a><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman"> 
				See: </span>
				<span style="font-size: 10.0pt; font-family: Times New Roman">
				Marsh, G.P.: <b><i>Man and Nature.</i></b> Edited by David 
				Lo­wen­thal. Har­vard University Press. Cambridge, Mass. 1965. 
				First pub­li­shed 1864</span><span lang="EN-GB" style="font-size: 10.0pt; font-family: Times New Roman">.</span></div>
		</div>
	</blockquote>
	<p></p>
  		</td>
          <td width="14" bgColor="white">
			<img height="1" src="../../1971/image_article/spacer.gif" width="14" border="0"></td>
          <td class="k" width="1" bgColor="#6fb1d9">
          <img src="../../1971/image_article/spacer.gif" border="0" width="1" height="1"></td>
        </tr>
        <tr>
          <td vAlign="top" align="left" colSpan="2" rowSpan="2">
          <img src="../../1971/image_article/blcurv.gif" border="0" width="19" height="15"></td>
          <td bgColor="white">
			<img height="14" src="../../1971/image_article/spacer.gif" width="1" border="0"></td>
          <td vAlign="top" align="right" colSpan="2" rowSpan="2">
          <img src="../../1971/image_article/brcurv.gif" border="0" width="15" height="15"></td>
        </tr>
        <tr>
          <td class="k" bgColor="#6fb1d9">
			<img height="1" src="../../1971/image_article/spacer.gif" width="150" border="0"></td>
        </tr>
      </tbody>
    </table>
  	<hr color="#FFFFFF">
	<table id="AutoNumber3" borderColor="#111111" cellSpacing="0" cellPadding="0" width="606" border="0">
		<tr>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../index.html">
			<img src="https://gold.mukto-mona.com/new_site/mukto-mona/images/index_r3_c1.gif" border="0" width="153" height="19"></a></td>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../new_site/mukto-mona/muk-secularnews.html">
			<img src="../../new_site/mukto-mona/images/index_r14_c1.gif" border="0" width="153" height="19"></a></td>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../new_site/mukto-mona/muk-projects.html">
			<img src="../../new_site/mukto-mona/images/index_r16_c1.gif" border="0" width="153" height="19"></a></td>
			<td style="line-height: 1.25em; font-family: arial,helvetica,sans-serif; font-size: 79%">
			<a href="../../new_site/mukto-mona/muk-forums.html">
			<img src="../../new_site/mukto-mona/images/index_r21_c1.gif" border="0" width="153" height="19"></a></td>
		</tr>
	</table>
  </div>
</blockquote>

</body>

</html>
